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Abstract  
There is much interest in the study of midbrain dopaminergic (mDA) neurons as their 
functions include the regulation of motor function, emotion and reward pathways. 
Furthermore the dysfunction of these neurons is implicated in a number of human 
disorders such as Parkinson’s disease (PD), addiction and schizophrenia. PD is 
characterised by the degeneration of mDA neurons of the substantia nigra pars 
compacta (SNc), therefore, research into the specification and development of mDA 
neurons is of particular interest in relation to this disease.  An understanding of the 
development of mDA neurons may lead to new methods of preventing their 
degeneration or potentially a human ES cell derived source of mDA neurons that 
could be used for transplantation in PD patients.  
Pitx3 is a bicoid-related homeodomain protein with an expression pattern restricted to 
the mDA neurons of the SNc and ventral tegmental area (VTA), within the central 
nervous system. To directly investigate a role for Pitx3 in mDA neuron development, I 
have analysed a line of transgenic mice with a green fluorescent protein (GFP) 
reporter under the control of the endogenous Pitx3 promoter. Use of the targeted 
GFP reporter as a midbrain dopaminergic lineage marker in the phenotypically 
normal heterozygous mice identified previously unrecognised ontogenetically distinct 
subpopulations of dopaminergic cells within the ventral midbrain. These 
subpopulations were detectable at E12.5 based on their temporal and topographical 
expression of Pitx3 and TH.   
Analysis of the Pitx3 null mice revealed that Pitx3 is required for the survival of a 
subset of nascent mDA neurons at the beginning of their terminal differentiation. The 
loss of mDA neurons via apoptosis continued throughout development resulting in a 
complete absence of SNc neurons whilst the VTA remained relatively intact in adult 
Pitx3 null mice. In addition, during embryonic development Pitx3 deficiency caused a 
loss of tyrosine hydroxylase (TH) expression specifically in the SNc dopaminergic 
neurons. Analysis of chimeric mice made with Pitx3 null and Pitx3 heterozygous ES 
cells revealed that Pitx3 acts in a cell autonomous manner. These findings point to 
two roles for Pitx3 in SNc mDA neurons, one in their survival and the other in 
regulation of TH expression. Taken together, these studies suggest that the 
ontogenetically distinct subpopulations may provide the molecular basis for the 
specific dependence of substantia nigra DA neurons on Pitx3.  
 
In addition, to establish whether the subpopulations identified at E12.5 do form the 
SNc and VTA, respectively, a strategy to track the fate of the earliest Pitx3-
expressing cells has been initiated. In order to achieve this I have created transgenic 
mice in which a tamoxifen inducible form of Cre recombinase is under the control of 
the endogenous Pitx3 promoter. These mice can be crossed with existing mice which 
contain a ubiquitously expressed Cre-inducible reporter, such as LacZ or GFP, to 
give a temporally and spatially restricted reporter expression.                                  
Chapter 1  
Introduction  
1.1. Midbrain dopaminergic neurons 
Dopamine containing neurons are present in various areas of the central nervous 
system (CNS) and are usually identified by the presence of tyrosine hydroxylase 
(TH), the rate limiting enzyme in dopamine biosynthesis. There are several groups of 
dopaminergic (DA) neurons in the CNS including the retina (A17), olfactory bulb 
(A16) and the diencephalic DA neurons (A11-14) (Bjorklund and Lindvall, 1984).  
However, the largest assembly of dopaminergic (DA) neurons in the brain are located 
in the ventral midbrain.  The majority of the midbrain dopaminergic (mDA) neurons 
form functionally distinct subgroups called the substantia nigra pars compacta (SNc, 
A9) and the ventral tegmental area (VTA, A10) based on their position within the 
midbrain and the target structures which they innervate (Fig. 1.1) (Bjorklund and 
Lindvall, 1984). There is much interest in the mDA neurons as they are essential for 
important brain functions and their dysfunction/degeneration is associated with a 
number of disorders.  Dopaminergic neurons of the SNc regulate motor function via 
nigro-striatal projections to the dorsolateral striatum and in humans the degeneration 
of SNc neurons results in Parkinson’s disease (PD). PD affects 1% of the population 
aged over fifty, and is characterised by a slowness of movement (bradykinesia) and a 
difficulty in initiating movement (akinesia). On the other hand, mDA neurons of the 
VTA project to the ventromedial striatum, cortical areas and the limbic system 
forming the mesolimbocortical system. This system is involved in the modulation and 
control of cognitive, emotional and reward pathways (Kelley and Berridge, 2002). 
Defects of the mesolimbocortical system are implicated in addiction and psychiatric 
disorders such as depression and schizophrenia (Dailly et al., 2004; Sesack and 
Carr, 2002).   
The current understanding of the specification and development of mDA neurons is 
limited. A number of factors involved have been identified, however, there are many 
gaps in the knowledge and the interactions between factors and the cascade of 
signalling events remain to be elucidated.  Due to the important roles of mDA 
neurons in a number of human diseases it is of interest to fully understand the 
specification and development of these neurons. Furthermore, this knowledge is 
necessary in order to realise the goal of creating pure populations of mDA neurons 
from embryonic stem (ES) cells in vitro. An ES cell-derived source of mDA neurons 
is desirable for a number of applications including pharmacological assays to 
analyse the activity of potential drug treatments for mDA system disorders and as a 
source of mDA neurons for transplantation studies in animal models of PD. The 
ultimate objective of the studies on the mouse ES cell system is to translate them to 
the human ES cell system, which may lead to the generation of human ES cell-
derived mDA neurons for drug screening and potentially for transplantation into PD 
patients.  
Both in vitro and in vivo studies will help to determine the key mediators involved in 
mDA neuron specification and development. In particular loss-of-function knockout 
studies are a powerful tool with which to elucidate the role of specific genes in 
embryonic mDA development. Although the in vitro system has more limitations, it is 
a convenient method for evaluating the effects of a variety of molecules, especially 
soluble factors, on undifferentiated cell populations.   
1.2. In vitro mDA neuron specification 
Since the exact requirements for differentiation of ES cells into specific cell lineages 
remains elusive, current differentiation protocols yield heterogeneous cell types.  So 
far there have been two protocols developed specifically to differentiate ES cells 
towards a DA fate, one involves cell aggregation and the application of Shh and 
Fgf8 (Lee et al., 2000) and the other is via co-culture of ES cells with PA6 stromal 
cells (Kawasaki et al., 2000). In addition, a serum-free adherent monolayer culture 
method has been developed in which ES cells can develop into neural precursors, 
and subsequently DA neurons can be produced upon addition of Fgf8 and Shh 
(Ying et al., 2003).  
Kawasaki and co-workers identified a stromal cell-derived inducing activity (SDIA) 
that efficiently induces neural differentiation from ES cells, with a high proportion of 
TH-positive neurons (Kawasaki et al., 2000). The nature of SDIA is unclear as PA6 
neural inducing activity remains when the cells are fixed thus unable to secrete 
soluble factors, or when the PA6 cells are separated from the ES cells by a filter. 
The authors suggest that SDIA may be a secreted factor that is secondarily tethered 
to the cell surface, as treatment with heparin removes the neural inducing activity 
(Kawasaki et al., 2000). Recently it has been shown that the factors mediating SDIA 
may be isolated in solution by treating PA6 cells with heparin and that the 
proliferative and neural differentiation effects of SDIA can be distinguished 
(Yamazoe et al., 2005). Using this method it was reported that TH-positive neurons 
appeared between days 6-8 of the induction period and constituted 30% of the total 
neurons in the culture (Kawasaki et al., 2000).   
Another approach for DA fate induction from ES cells involves the addition of Shh 
and Fgf8 (Lee et al., 2000). This protocol starts with a short period of embryoid body 
(EB) differentiation followed by medium-based selection for nestin-positive neural 
precursor cells.  The neural precursors are then expanded using Fgf2 before being 
induced to a DA fate by addition of Fgf8, Shh and ascorbic acid. The authors 
demonstrated that it was possible to obtain TH-expression in over 30% of the 
neurons (Lee et al., 2000).  Using a similar approach, Rolletschek et al. use an 
array of survival-promoting factors in the production of DA neurons from ES cells 
(Rolletschek et al., 2001).  They found that a cocktail containing interleukin-1
 
(IL-
1 ), glial cell line-derived neurotrophic factor (GDNF), neurturin (NTN), transforming 
growth factor- 3 (TGF- 3), and dibutyryl-cAMP (db-cAMP) could enhance RNA 
expression levels of En1, Mash-1, dopamine receptor 2 (D2R), TH and Nurr1 and 
increase the proportion of TH-positive and dopamine active transporter (DAT)-
positive neurons from around 20% to around 40% (Rolletschek et al., 2001). 
However, it remains to be established as to the extent of those ES cell-derived DA 
neurons that express a midbrain phenotype.  
An important caveat in many studies on mDA differentiation from ES cells is the use 
of markers in their analysis. Indeed, many in vitro studies assess mDA neuronal 
phenotype by determining TH expression in cultured cells.  However, this has 
limitations as TH is expressed in all catecholaminergic neuronal types including 
adrenergic and noradrenergic neurons. Furthermore, other DA markers such as 
DAT, L-aromatic amino acid decarboxylase (AADC) and dopamine receptors are 
expressed in DA cells in other CNS regions including the olfactory bulb and the 
diencephalic DA cell groups located in the arcuate nucleus, periventricular nucleus, 
caudal thalamus, and hypothalamic regions (Bjorklund and Lindvall, 1984). Analysis 
of DA differentiation of Pitx3-GFP ES cells with the PA6 co-culture method revealed 
that the vast majority of Pitx3-GFP positive neurons express TH (Zhao et al., 2004). 
However, only around 10-15% of all TH or DAT expressing cells co-express Pitx3-
GFP, suggesting that not all of the DA neurons generated by this method display a 
mesencephalic character (Zhao et al., 2004). Therefore, ES cell-derived 
dopaminergic neurons in vitro are heterogeneous and do not all exhibit 
mesencephalic identity. This is significant as functional repair of PD appears to be 
specifically associated with mesencephalic grafts as demonstrated by 
transplantation experiments (Hudson et al., 1994).   
1.3. Midbrain specification in vivo 
Diverse neural cell types are generated in the nervous system from multipotent 
neural progenitor cells.  Accordingly, the specification of cell fate is complex and is 
governed by the interplay of extrinsic and intrinsic signalling molecules, combined 
with cell-type and temporal specific factors. A grid-like set of positional identities is 
given to neural progenitors via gradients of signalling molecules secreted 
throughout the dorsal-ventral and rostral-caudal axes of the neural tube.  The floor 
plate and roof plate along the neural tube act as inducing centres and in addition, 
secondary organisers act as local signalling centres to further refine cell fates at the 
rostral-caudal level.  Once neuronal fate has been restricted by these extrinsic cues, 
intrinsic signals, often transcription factors direct further differentiation into a mature, 
postmitotic neuron (Edlund and Jessell, 1999; Lumsden and Krumlauf, 1996; Stern, 
2001)   
During embryogenesis mDA neurons are specified in the ventral mesencephalon 
just rostral to the isthmic organiser (IsO) and in close proximity to the floor plate 
(Fig. 1.2). The IsO is a signalling centre located at the border between the midbrain 
and the hindbrain (the mid-hindbrain boundary, MHB) and its position determines 
the location and size of the mDA neuron population (Brodski et al., 2003).  
Accordingly, the correct specification of the IsO is necessary for the development of 
midbrain structures.  Many molecules involved in establishing and patterning the 
midbrain are expressed in a complicated network of regulation in the isthmic region, 
which has not yet been fully uncovered.  At the end of gastrulation, embryonic day 
(E) 7.5 in mouse, the future position of the IsO is identified where the expression 
domains of the transcription factors Otx2 and Gbx2 meet.  Otx2 is expressed on the 
rostral side and Gbx2 is expressed on the caudal side of the IsO, and they are 
required to suppress hindbrain and midbrain development respectively (Li and 
Joyner, 2001).  Also expressed from this stage is the homeobox transcription factor 
Lmx1b, which is initially expressed throughout the ventral mesencephalon and 
diencephalon and is later restricted to post-mitotic mDA neurons (Smidt et al., 
2000). At E8, the transcription factor Pax2 is expressed across the Otx2/Gbx2 
border and expression of the secreted molecule Wnt1 is predominantly limited to 
the Otx2 domain (Wurst and Bally-Cuif, 2001) (Fig. 1.2). Following this, the 
transcription factors En1, En2 and Pax5 are expressed across the Otx2/Gbx2 
border, and fibroblast growth factor 8 (Fgf8) is expressed on the Gbx2-positive side 
(Wurst and Bally-Cuif, 2001).   By E9.5 the expression of Wnt1 and Fgf8 domains 
have sharpened into rings on rostral and caudal sides of the IsO, respectively 
(Wurst and Bally-Cuif, 2001). Otx, Lmx1b and Wnt1 are expressed on the midbrain 
side of the IsO whilst Gbx2 and Fgf8 are expressed on the hindbrain side.    
1.4. Factors involved in mDA neuron specification and development 
The correct specification and development of mDA neurons depends upon a 
number of extrinsic and intrinsic signalling factors which interact to create a specific 
identity code for mDA neurons. The majority of studies report the first mDA neurons 
detected by the presence of TH at E11.5 (Foster et al., 1988; Solberg et al., 1993; 
Zetterstrom et al., 1997), however TH expression in the mesencephalon as early as 
E9.5 has been reported (Di Porzio et al., 1990). The mechanisms involved in the 
regulation of TH expression in mDA neurons remain unclear. It appears, however, 
that TH is not required for mDA development, as TH-deficient mice have an 
apparently intact mDA system with normal projections to target tissues in the 
telencephalon (Zhou and Palmiter, 1995).  Prior to TH expression the earliest 
known marker for mDA neuron progenitors is retinaldehyde dehydrogenase 1 
(Aldh1, also known as AHD2), which is expressed at E9.5 in mDA progenitors and 
expression continues in mDA neurons throughout development (Wallen et al., 
1999). The function of Aldh1 is to oxidise retinaldehyde into retinoic acid, however, 
a possible role for Aldh1 in mDA neuron development has not been investigated. 
Subsequently the first post-mitotic mDA precursors can be detected at around 
E10.5 identified by the expression of Nurr1 (see below). Studies using 
autoradiographic methods in the developing rat brain have demonstrated that most 
post-mitotic cells of the mDA system emerge between E11 and E15 (approximately 
equivalent to E10-E14 in mouse), with a peak of SNc neurons emerging at E13-E14 
(E12-E13 in mouse) and VTA neurons at E14-E15 (E13-E14 in mouse) (Altman and 
Bayer, 1981; Hanaway et al., 1971; Lauder and Bloom, 1974).  Some extrinsic and 
intrinsic factors that are implicated in mDA specification and development are 
discussed below.  
 
1.4.1. Shh and Fgf8 
The intersection of the floor plate-derived signal Sonic hedgehog (Shh) with the 
isthmus-derived Fgf8 creates an inductive centre for mDA neurons just rostral to the 
IsO (Fig. 1.2). It has been shown that Shh is necessary and sufficient for the 
induction of mDA neurons along the dorso-ventral axis, whereas Fgf8 is responsible 
for the position of mDA neurons along the anterior-posterior axis of the neural tube 
(Ye et al., 1998). However, recent studies have highlighted that the mDA-inducing 
effects of Shh and Fgf8 are complex and that interactions with other factors are 
required for correct cell-type specification in the midbrain. It was shown that as well 
as determining the rostral-caudal position of Fgf8 signalling (Ye et al., 2001), Otx 
genes also control Shh distribution along the dorsal-ventral axis in a dose-
dependent repressive manner (Puelles et al., 2003). Furthermore Otx2 has a role in 
the formation and maintenance of ventral midbrain progenitor domains as defined 
by the expression pattern of Shh and the Shh-responsive class II homeobox 
transcription factors Nkx6.1 and Nkx2.2. Selective disruption of Otx2 expression in 
the ventral and lateral midbrain results in a considerable reduction in mDA neurons 
and an induction of progenitors with a rostral hindbrain identity, even though Fgf8 
expression remains intact (Puelles et al., 2004). However, recent fate mapping 
studies have shown that mDA precursors are only responsive to Shh between 
E7.75 and E9 and beyond this stage mDA neurons are generated from non-Shh 
responsive precursors, thus they are specified independent of Shh signalling. The 
subtype and the number of mDA neurons formed from the Shh-responsive cells 
remains unclear (Zervas et al., 2004).     
1.4.2. Wnt 
The Wnt family of glycoproteins are signalling molecules with key roles in regulation 
of patterning, cell proliferation and cell determination in the embryo. Furthermore, 
within the nervous system Wnt proteins are involved in virtually all significant 
patterning events (Patapoutian and Reichardt, 2000).  Wnt1 is expressed around 
the IsO, predominantly on the midbrain side.  A key role for Wnt1 in midbrain 
development was demonstrated by loss of function studies which revealed a failure 
by Wnt1-deficient embryos to develop any midbrain or anterior hindbrain structures 
(McMahon and Bradley, 1990; McMahon et al., 1992). Later, complementary 
misexpression studies in the chick demonstrated a role for Wnt1 in the formation 
and maintenance of the IsO. In this study, Wnt1 was shown to be able to induce 
Fgf8 expression, which in turn induces the expression of Lmx1b (Matsunaga et al., 
2002). More recently fate mapping studies have revealed that cells in the 
mesencephalon expressing Wnt1 from E7.75 to E11.5 give rise to mDA neurons 
(Zervas et al., 2004). Therefore, Wnt1 may have a significant role in the 
specification of mDA neurons.  
In addition to Wnt1, Wnt5a is also expressed at a high level in the ventral midbrain, 
with a peak at E11.5 in rat (Castelo-Branco et al., 2003).  The addition of Wnt5a to 
rat E14.5 ventral midbrain primary cultures resulted in an increase in the number of 
TH-expressing neurons. Furthermore, there was an increase in the overall 
expression levels of Pitx3 and c-ret in cultures treated with exogenous Wnt5a. From 
these studies the authors suggested that Wnt5a increases the total number of mDA 
neurons by promoting the acquisition of mDA phenotype, whilst Wnt1 acts as a 
general midbrain mitogen (Castelo-Branco et al., 2003).   
1.4.3. Nurr1 (Nr4a2) 
Nurr1 (also known as Nr4a2) is a member of the orphan nuclear receptor family of 
transcription factors and is expressed in the ventral mesencephalic flexure from 
mouse E10.5 onwards (Zetterstrom et al., 1997).  In addition, Nurr1 is also 
expressed in other brain regions including neocortex, hypothalamus, hippocampus 
and cerebellum (Zetterstrom et al., 1996).  Nurr1 deficient mice lack TH-expression 
in the ventral midbrain from E11.5, other DA neuronal markers including the retinoic 
acid converting enzyme Aldh1, c-ret and the D2R are also absent from the adult 
SNc and VTA (Zetterstrom et al., 1997). Further studies have revealed that Nurr1 
deficient neuroepithelial cells undergo normal ventralisation and differentiate into 
Pitx3 expressing neurons (Saucedo-Cardenas et al., 1998). The expression of En1, 
En2, Aldh1 and AADC has also been demonstrated in midbrain cells of E11.5 Nurr1 
mutant mice, although the expression of these markers is reduced or absent by 
E15.5 (Smits et al., 2003; Wallen et al., 1999).  These early Nurr1 deficient midbrain 
neurons do not express DA neuron markers such as TH and vesicular monoamine 
transporter 2 (VMAT2) (Smits et al., 2003) and subsequently die by apoptosis 
resulting in a severe loss of SNc and VTA cells by neonate stage. In addition the 
mDA markers that were expressed in Nurr1 mutant mice by E15.5 are medially 
located.  A further investigation into the distribution of the mutant Nurr1 mRNA 
expression in Nurr1 null brains revealed that Nurr1 null mDA neurons fail to migrate 
laterally to their normal positions during development and are unable to innervate 
their target tissue, the striatum (Wallen et al., 1999).  Thus, Nurr1 is required for 
specific features of the dopaminergic phenotype, is necessary for the survival of late 
dopaminergic neurons and may also have a role in the migration of mDA neurons.  
1.4.4. Engrailed 
Engrailed is a homeodomain transcription factor that has two vertebrate 
homologues, En1 and En2. Both En1 and En2 are expressed in the developing 
mouse brain from E8 on either side of the IsO in the midbrain and hindbrain (Davis 
and Joyner, 1988).  In adulthood En1 and En2 have a more limited expression 
pattern. In the midbrain, En1 is expressed throughout the SNc and VTA at high 
levels, whereas En2 is expressed at lower levels and is restricted to a subset of the 
En1 expressing cells (Simon et al., 2001).  In addition, En1 and En2 are expressed 
in motor nuclei of the pons and En2 is expressed in the cerebellum (Davis and 
Joyner, 1988).  En1 null mice have major brain defects during embryonic 
development, including deficits in the midbrain, hindbrain, colliculi, cerebellum and 
the third and fourth cranial nerves (Wurst et al., 1994). Yet, mDA neurons are 
present in En1 null mice at P0, and En2 expression is up-regulated in these cells 
(Simon et al., 2001).  The En2 knockout phenotype is milder with no gross mid-
hindbrain abnormalities (Joyner et al., 1991). In contrast, the compound mutation of 
En1 and En2 results in a complete absence of both SNc and VTA DA neurons by 
E14. At E12 however, TH-positive neurons are present in the ventral midbrain of 
En1/2 double mutants although there are fewer cells than in the wild type controls. 
At E13 the number of TH-positive cells is more reduced in the En1/2 double 
mutants and some of the remaining TH-positive cells display signs of apoptosis 
(Alberi et al., 2004).  However, there is a substantial truncation of the midbrain and 
anterior hindbrain in the engrailed double mutants resulting in a loss of the isthmus 
and reduced levels of Shh and Fgf8 (Simon et al., 2001).  Accordingly it is difficult to 
make assumptions about the function of En1 and En2 in mDA neuron development 
in a situation where key midbrain structures and developmental signalling factors 
are aberrant. However, a recent study has addressed this by performing primary 
culture experiments with E12 En1/2 double mutant midbrain cells. This revealed 
that the requirement for En1 and En2 is cell autonomous and is independent of the 
mDA neuron environment.  It was shown that mDA neurons lacking En1 and En2 
died via apoptosis in vivo and in primary culture (Alberi et al., 2004). Thus the 
engrailed genes appear not to be required for mDA neuron specification but are 
required for their survival.  
1.4.5. Lmx1b 
Lmx1b is a LIM class homeobox (LIM-HD) gene that is expressed in the CNS and in 
the periphery where it is necessary for dorsoventral patterning of limbs (Riddle et 
al., 1995).  During development Lmx1b is expressed in many areas of the CNS 
including those that give rise to SNc, VTA, Raphe nuclei, subthalamic nucleus 
(STN), posterior hypothalamus and the spinal cord (Asbreuk et al., 2002).  Recently 
it has been reported that Lmx1b is required for serotonergic neuron development in 
the hindbrain (Ding et al., 2003). Lmx1b is expressed throughout the 
mesencephalon and diencephalon from E7.5 in mice and expression in the SNc and 
VTA has been reported from E12 onwards (Nunes et al., 2003; Smidt et al., 2000).  
Studies on Lmx1b null mice have revealed that a loss of Lmx1b results in the failure 
of proper mDA neuron development.  At E12.5 there is a reduction in the number of 
TH-expressing cells and an absence of Pitx3 expression in the ventral midbrain of 
Lmx1b null mice.  However, Nurr1 expression in the ventral midbrain is intact in 
Lmx1b null mice at E12.5.  From E16 onwards, TH expression is not detected in the 
mutant ventral midbrain (Smidt et al., 2000).  As Lmx1b is expressed early (E7.5 in 
mouse) during CNS patterning events and has a widespread expression pattern in 
the brain, it is difficult to draw conclusions about a direct role for Lmx1b in mDA 
neurons from this study.  Further experiments are needed to address the cell 
autonomous functions of Lmx1b in mDA neurons.  However, the knockout study 
suggests that Nurr1 is not regulated by Lmx1b and that Pitx3 might be a target of 
Lmx1b.     
1.5. Pitx3 
Pitx3 was identified by two groups at approximately the same time: Semina et al 
(1997) aimed to further characterise the Pitx family by screening a mouse cDNA 
library with a probe comprising the Pitx2 HD, which led to the identification of Pitx3. 
Expression studies demonstrated that Pitx3 mRNA was expressed in the lens of the 
eye from E11.  Pitx3 was mapped on mouse chromosome 19 close to aphakia.  
Also, distinct mutations in the human homologue of the mouse Pitx3 gene have 
been identified in patients with cataracts and anterior segment mesenchymal 
dysgenesis (ASMD) (Semina et al., 1998). On the other hand, Smidt et al (1997) 
identified Pitx3 while searching for homeobox genes associated with a unique 
neuronal lineage.  Using in situ hybridisation they demonstrated that within the CNS 
Pitx3 is exclusively expressed in the SNc and VTA and is superimposed with TH 
expression.  In developing mice Pitx3 mRNA expression is first detected in the 
midbrain at E11.5 as a small layer at the ventral surface of the mesencephalic 
flexure.  This layer corresponds to the first TH-expressing cells in the mouse brain.   
In situ hybridisation studies on human brains revealed that Pitx3 was expressed in 
pigmented substantia nigra neurons and there were fewer Pitx3-expressing cells in 
the substantia nigra of patients with PD (Smidt et al., 1997). As well as the eyes and 
the midbrain Pitx3 expression was also reported in the tongue, incisor primordia, 
mesenchyme around the sternum and vertebrae and in the head muscles (Semina 
et al., 1998; Smidt et al., 1997).   
So far few potential Pitx3 targets and/or co-factors have been identified. A role for 
Pitx3 in the induction of TH expression has been suggested by the demonstration 
that Pitx3 can bind to response elements and activate the TH promoter in a cell 
type-dependent manner (Cazorla et al., 2000; Lebel et al., 2001).  However, 
overexpression of Pitx3 in adult hippocampus-derived progenitor cells had no effect 
on the expression of DA neuron markers including the dopamine synthesising 
enzymes TH and AADC, the neurotrophic factor GDNF, the signal transducing 
receptors c-ret and GFRalpha-1 and the D2 dopamine receptor (D2R) (Sakurada et 
al., 1999).  This implies that, unlike Nurr1, which can induce a DA phenotype in both 
neuronal and non-neuronal cells (Sonntag et al., 2004), Pitx3 may require cell type 
specific factor(s) to regulate TH expression.  A potential Pitx3 co-factor may be 
Nurr1, as it has been suggested that Pitx3 and Nurr1 cooperate to regulate TH 
expression, and that Pitx3 may be involved in the maintenance of TH expression 
(Cazorla et al., 2000).    
1.6. Pitx gene family 
Homeobox genes encode transcription factors that have been shown to mediate key 
processes in development and patterning.  The Pitx proteins belong to the bicoid-
related subclass of paired homeodomain proteins, as they have a lysine at residue 
50 in the homeodomain region (position 9 in the recognition helix of the 
homeodomain), which determines the DNA binding specificity of these proteins.  Few 
bicoid-related homeodomain genes have been identified in mammals: they include 
goosecoid and the Otx1 and Otx2 genes.  Goosecoid is expressed by organizer cells 
and the anterior visceral endoderm in the vertebrate embryo, and it has been 
proposed that it plays a role in the regulation of neural inducing activity (Sawada et 
al., 2000; Zhu et al., 1999).  Otx1 has multiple roles in the developing and adult 
mouse, and is required for correct brain and sense organ development.  Otx2 plays a 
key role in anterior neural patterning and is required for the correct positioning of the 
isthmic organiser and mDA neuron specification (Acampora et al., 2001; Puelles et 
al., 2004).    
Three members of the Pitx family have been identified: Pitx1, Pitx2 and Pitx3.  They 
share a high amino acid sequence homology, for example, in mouse the 
homeodomains of Pitx2 and Pitx3 are identical and the homeodomain of Pitx1 has 
96% homology to this (Fig. 1.3). The C-terminal domains of Pitx1, Pitx2 are around 
50% conserved relative to Pitx3, however Pitx1 and Pitx2 isoforms have 70% amino 
acid identity. In addition there is a conserved 14 amino acid region at the C-terminus 
known as the OAR sequence which is present in several homeodomain genes. It has 
been shown that the C-terminal of Pitx2 containing the OAR region functions as an 
inhibitor of DNA binding activity and involved in protein-protein interactions (Amendt 
et al., 1999). Similarly, studies on Pitx2 have revealed that the N-terminal region is 
also important for regulating Pitx2 transcriptional activity (Amendt et al., 1999), 
however, the N-terminal domains of the Pitx family members are largely disparate.   
1.6.1. Pitx1 
Pitx1 was identified as a transcription factor involved in activation of pituitary-specific 
gene transcription of pro-opio melanocortin (POMC) (Lamonerie et al., 1996). As well 
as the pituitary, Pitx1 expression has been detected in the stomodeum, the first 
branchial arch mesenchyme, oral ectoderm and lateral plate mesoderm (Lanctot et 
al., 1997).  In the pituitary, Pitx1 binds a promoter regulatory element with a 
sequence related to the Drosophila bicoid binding sequence, and acts in synergy with 
other cell-restricted factors to activate the POMC gene (Drouin et al., 1998; 
Lamonerie et al., 1996). Additionally, recent studies have revealed that Pitx1 may act 
in a positive auto-regulatory manner dependent on its DNA-binding and trans-
activation domains (Goodyer et al., 2003). Other roles that have been attributed to 
Pitx1 include early hindlimb bud formation (Marcil et al., 2003). More recently Pitx1 
has been shown to have a role as a tumor-suppressor gene in human cells, 
functioning to down-regulate the RAS pathway via direct transcriptional activation of 
RASAL1 (Kolfschoten et al., 2005).   
1.6.2. Pitx2 
Pitx2 was identified by positional cloning of the Rieger syndrome gene in humans. 
Mutations in one allele Pitx2 may cause Rieger syndrome, which is characterised by 
abnormalities of the anterior chamber of the eye, dental hypoplasia, craniofacial 
dysmorphism and iris hypoplasia (Semina et al., 1997). Similarly in mice there is a 
Pitx2 haploinsufficiency defect which recapitulates features analogous to human 
Rieger syndrome (Gage et al., 1999b).  Major sites of Pitx2 expression in mice 
include eye, pituitary, forelimb and hindlimb mesenchyme, teeth, heart, forebrain and 
midbrain (Gage et al., 1999a). The complete loss of Pitx2 is lethal by E14.5 due to 
profound heart defects; also there are major abnormalities in the eyes, teeth, pituitary 
and lungs (Gage et al., 1999b; Kitamura et al., 1999; Lin et al., 1999). Roles for Pitx2 
have been demonstrate in anterior structure formation (Gage and Camper, 1997), 
hindlimb bud development (Marcil et al., 2003) and multiple stages of pituitary 
development, where it acts in synergy with Pitx1 (Suh et al., 2002). A role for Pitx2 in 
vertebrate patterning of laterality has been demonstrated, as it appears to be the 
most downstream gene in the Shh/nodal/lefty-2 pathway controlling left-right 
patterning (Logan et al., 1998; Piedra et al., 1998; Yoshioka et al., 1998). 
Additionally, it has been proposed that Pitx2 has a role as a regulator of gamma-
aminobutyric acid (GABA)-ergic neuron differentiation during mammalian neural 
development.  Pitx2 is an ortholog of unc-30, a C.elegans gene that directly regulates 
glutamic acid decarboxylase (GAD, enzyme required for GABA biosynthesis) 
synthesis and has a central role in the specification of the GABAergic 
neurotransmitter phenotype.  Pitx2 is expressed in regions where GABAergic 
neurogenesis occurs thus it may have a role in regulating GAD expression in 
mammals (Westmoreland et al., 2001).     
1.7. Hypotheses and aims 
Based on the restricted expression pattern of Pitx3 in mDA neurons combined with 
the fact that Pitx3 is a homeodomain transcription factor, which are typically involved 
in regulating development, the hypothesis was formed that Pitx3 may have a role in 
the development of mDA neurons. Therefore, the aim of this study is to investigate 
the role, if any, of Pitx3 in mDA neurons. Firstly the expression of Pitx3 in mDA 
neurons in mouse embryo and adult will be assessed to confirm the restriction of 
Pitx3 expression to mDA neurons within the CNS and the expression in both VTA 
and SNc neurons. Then, in order to understand the functional significance of Pitx3 in 
vivo the phenotype of mice that lack Pitx3 will be analysed.  
  
Figure 1.1. Schematic diagram showing the anatomy of midbrain dopaminergic 
neurons. 
Diagrams of coronal sections through the midbrain (A) and the forebrain (B) show the 
location of the SNc and VTA neurons in the midbrain and their target areas of the 
striatum which are the dorso-lateral caudate putamen (CPu) for the SNc and the 
ventral CPu, nucleus accumbens (NA) and olfactory tubercle (OT) for the VTA. 
                     
Figure 1.2. Schematic diagram showing position of mDA neuron specification 
and expression of genes during embryonic development. 
The diagrams show a sagittal view of mouse neural tube at around E8 (A) and E11 
(B) with the expression pattern of some genes involved in midbrain and mDA neuron 
development.  At E8 (A) the expression domains of Otx2 and Gbx2 meet at the 
midbrain/hindbrain boundary (Isthmic organiser, IsO). The expression of Wnt1, Pax2, 
Pax5 and Otx2 overlaps in the midbrain region and Fgf8 is expressed on the caudal 
side of the IsO. The position where the mDA neurons will first appear is outlined in 
red (adapted from (Simon et al., 2003)). At E11 (B) the expression of Wnt1 and Fgf8 
is restricted to narrow rings on either side of the IsO. The expression domain of 
Pax2/5 has also become narrower. The mDA neurons (red) are generated in the 












Figure 1.3. Diagram showing structure and amino acid identity between Pitx 
family genes. 
The diagram shows the percent amino acid identity of Pitx family genes relative to 
Pitx3 within the homeodomains (spotted) and the regions N- and C-terminal to the 
homeodomain. The C-terminal OAR sequence is also indicated (striped) and it is fully 
conserved between Pitx3 and all Pitx2 isoforms, whereas the Pitx1 OAR sequence 

















Chapter 2   
Materials and Methods  
2.1 Materials 
Unless otherwise stated analytical grade chemicals were obtained from either Sigma 
or BDH Laboratory Supplies (Merc Ltd).  Stock solutions were prepared with reverse 
osmosis purified (ROP) water and filtered or autoclaved as necessary. Agarose for 
electrophoresis was supplied by Invitrogen. Synthetic oligonucleotides were 
synthesised by SIGMA. Radiosotypes were supplied by Amersham Biosciences.   
2.1.1. Solutions 
Phosphate buffered saline (PBS): 
2.7 mM KCl, 137 mM NaCl, 4.3 mM Na2HPO4.7H2O, 1.4 mM KH2PO4 (pH 7.4).  
PBST: 
0.2% (v/v) Triton X-100 (BDH) and 1% (w/v) bovine serum albumin (BSA) in PBS.  
1X TAE: 
0.04M Tris-acetate, 0.001M EDTA  
20X SSC: 
3M NaCl, 0.3M tri-Na citrate  
Lysis buffer: 
10mM Tris (pH 8.0), 50mM EDTA, 100mM NaCl, 0.5% SDS, 0.5mg/ml Proteinase K 
(Roche) added just before use.  
Glasgow minimum essential medium (GMEM):  
1X GMEM (Sigma), 10% (v/v) fetal bovine serum (Gibco), 1mM sodium pyruvate 
(Gibco), 1X MEM non-essential amino acids (Gibco), 2mM I-glutamine (Gibco), 
0.1mM 2-mercaptoethanol (BDH).  
Luria-Bertani (LB) broth: 
1% (w/v) tryptone (Difco), 0.5% (w/v) yeast extract, 85mM NaCl.  
LB agar: 
1.5% (w/v) agar (Difco) in LB broth.  
MOPS (10X): 
0.2M MOPS (pH 7.0) 
20mM sodium acetate 
10mM EDTA (pH 8.0)  
TFB1:  
30mM potassium acetate, 10mM CaCl2, 50mM RbCl,, 15% glycerol, pH adjusted to 
5.8 with 1M acetic acid and filter sterilised.  
TFB2:  
10mM MOPS, 75mM CaCl2, 10mM RbCl, 15% glycerol, pH adjusted to 6.5 with 1M 
KOH and filter sterilised.  
Depurination solution:  
11ml HCl, 989ml dH2O  
Denaturation solution:  
87.66g NaCl, 0.4M NaOH. Make up to 1L with distilled H2O.  
Church & Gilbert hybridisation buffer: 
0.5M Na2HPO4 (pH 7.2), 70g/L SDS, 1mM EDTA.  
Southern blot prehybridisation/hybridisation solution:  
0.2mg/ml salmon sperm DNA (denatured by boiling in a waterbath for 10 mins), 1mM 
NaOH, 4.5mM Tris HCl pH 8.0 in Church & Gilbert hybridisation buffer at 65ºC.  
STE buffer:  
10mM Tris-Cl (pH 8.0), 0.1M NaCl, 1M EDTA (pH 8.0).  
2.2 Animal analysis 
Mice were housed and bred in the Biomedical Unit within the Institute for Stem Cell 
Research, according to the Animals (Scientific Procedures) Act (UK) 1986. Mice 
were kept in a 12 hours dark, 12 hours light cycle with the midpoint of the dark cycle 
at 1am. For collection of embryos, matings were set up and female mice were 
checked daily before 10am for the presence of a vaginal plug and if present then 
1pm on that day was designated as embryonic day (E) 0.5. Mice aged 6 weeks or 
older were used for mating. Litters were left with their mother until 3 weeks of age 
when they were weaned by separating the offspring from the parent. At weaning the 
mice were sexed and tail tips were taken for genotyping. Maintenance of the mice, 
breeding set-up and tail biopsies were performed by the Biomedical Unit staff at the 
Institute for Stem Cell Research.  
2.2.1. Vibratome sectioning 
Embryos were dissected in PBS, then fixed in 4% paraformaldehyde (PFA) in PBS 
(pH 7.4) at 4°C overnight (for E12.5 and older) or 4 hours (E10.5 to E11.5), before 
embedding embryos in 2% agarose.  Embryos were then cut on a vibratome at 
100µm and mounted on slides. A Leica MZ FLIII Fluo Combi Stereo microscope and 
Openlab software were used to collect images.  
2.2.2. Cryostat sectioning 
Embryos and adult brains were dissected in PBS, then fixed in 4% PFA in PBS (pH 
7.4) overnight for E12.5 and E14.5 or 4 days for adult brains. The embryos or brains 
were then cryoprotected by placing them in a solution of 30% sucrose in PBS, which 
was left at 4°C until the embryo or brain sinks. Embryos and brains were then 
embedded in OCT (BDH) in foil parcels over dry ice and stored at -80°C until use.  
Cryostat sectioning was performed at -16 to -19°C using a Leica CM 1900 cryostat 
and sections were cut at 20µm. Sections were collected on polysine slides (BDH) 
and allowed to dry at room temperature for 30 minutes and then were either used 
immediately or stored at -80°C until use.  
2.2.3. Wax sectioning 
Brains from newborn mice were washed twice in PBS and dehydrated through an 
ethanol series (1 wash 70% ethanol, 1 wash 95% ethanol, 3 washes 100% ethanol 
for 1 hour each wash) followed by clearing in xylene overnight. Embryos were then 
incubated through 3 washes of wax at 60°C for 1 hour each before embedding in 
wax. Brains were sectioned at 7µm on a microtome (Anglia Scientific) and collected 
on polysine slides (BDH). Sections were dewaxed in xylene and then processed for 
immunohistochemistry or histological staining.  
2.2.4. Immunohistochemistry 
Frozen sections were allowed to equilibriate to room temperature. Sections were 
blocked with 3% normal serum in PBST for 1 hour at room temperature. Prior to the 
blocking step, sections to be visualised with DAB were incubated in 3% H2O2 in 
methanol for 15 minutes at 4°C to quench endogenous peroxidase activity.   Then 
sections were incubated with primary antibodies in blocking solution at 4°C overnight 
in a humidified box. Sections were washed three times for 20 minutes each in PBST, 
then incubated with horse radish peroxidase (HRP)- or fluorescence-conjugated 
secondary antibodies at room temperature for 1 hour or overnight at 4°C, 
respectively.  Sections to be visualised with DAB were incubated with biotinylated 
anti-rabbit IgG (Vectastain Elite, ABC kit; Vector Labs) for 1 hour at room 
temperature followed by avidin-biotinylated-peroxidase complex for 1 hour at room 
temperature, then DAB substrate until colour developed. After washing three times 
with PBS, cell/sections were mounted in Immunofluore (ICN Biomedicals) and 
analyzed using a Zeiss Axiophot microscope or Leica confocal microscope.   
2.2.4.1. Antibodies 
Primary antibodies: 
Antigen Species Supplier Concentration 
tubulin3 mouse Babco 1:500 
Caspase-3 active rabbit R&D systems 1:1000 
Engrailed 1 rabbit Developmental Studies 
Hybridoma Bank 
1:100 
GAD rabbit Sigma 1:3000 
GFP chicken Chemicon 1:1000 
Ki67 rabbit Novocastra 1:500 
Pitx3 rabbit Gift from M. Smidt 1:500 
TH rabbit Pel-Freeze 1:1000 
  
Secondary antibodies: 
Conjugant Antigen Species Supplier Concentration 
Alexa Fluor 488 chicken IgG goat Molecular Probes 1:1000 
Alexa Fluor 568 mouse IgG goat Molecular Probes 1:1000 
Alexa Fluor 568 rabbit IgG goat Molecular Probes 1:1000 
  
2.2.5. TUNEL labelling 
Cryostat sections were processed as described for immunostaining with anti-GFP 
antibody, then treated according to manufacturers instructions using ApopTag Red In 
Situ Apoptosis Detection Kit (Chemicon).    
2.2.6. Nissl staining 
Wax sections from neonate brain were de-waxed in xylene (BDH) and hydrated to 
dH2O by taking them through an alcohol series. Sections were stained in a 0.1% 
Cresyl fast violet (Sigma) solution for 5 minutes then rinsed in distilled water. The 
stain was differentiated by washing slides in 95% ethanol for 5-30 minutes and 
checking microscopically. Slides were then dehydrated and cleared in xylene before 
mounting in DPX mounting medium (Fisher Chemicals).   
2.2.7. Quantitative analysis of immunolabelled cells 
To determine the total number of TH and Pitx3-GFP immunolabelled cells present in 
the E12.5 and E14.5 midbrain, all labelled cells were counted in serial coronal 
sections (30 µm thick) of an entire midbrain. Total counts from four or five E12.5 and 
E14.5 embryos of each genotype (wild type, Pitx3-heterozygous (+/-) and Pitx3-
homozygous (-/-) were averaged and standard deviations were calculated. At E12.5 
cells do not exhibit typical SNc and VTA architecture and so were all counted 
together. At E14.5 many sections exhibit typical SNc and VTA architecture, however 
some sections crossing the rostral and caudal part of midbrain do not. This caused 
difficulties in terms of categorising labelled cells into either the SNc or VTA group 
accordingly for all sections. Therefore, to determine the relative number of DA 
neurons present in either SNc or VTA, we carried out comparative counts by 
examining 5 typical sections obtained for each genotype (Fig 2. C, D). Statistical 
analysis for the counting data was performed using two samples student t-test.   
2.3. Molecular biology methods  
2.3.1. Preparation of XL-1 blue competent cells by rubidium chloride method 
Agar stock XL-1 blue cells were grown on LB agar plates with 20µg/ml tetracycline at 
37°C overnight. Colonies were picked and each added to 2.5 ml LB media with 
20µg/ml tetracycline and incubated in a shaker at 37°C overnight. The 2.5ml cultures 
were added to 250ml of LB media with 20mM MgSO4 and incubated in a 1L flask in a 
shaker at 37°C for 5-6 hours, until the A600 reached 0.4 to 0.6. The 250ml cultures 
were centrifuged at 4500g for 5 minutes at 4ºC. From this stage the protocol was 
carried out in a room at 4°C with all equipment chilled. The cell pellet was gently 
resuspended in 0.4 volumes (100ml) of ice-cold solution TFB1 and incubated on ice 
for 5 minutes. The cells were centrifuged at 4500g for 5 minutes at 4°C. The cell 
pellet was gently resuspended in 1/25 original culture volume (10ml) of ice cold 
solution TFB2. The cells were incubated on ice for 15-60 minutes before aliquoting 
200µl per tube and quick-freezing on dry ice. Tubes were then stored at -80°C.  
2.3.2. Cloning 
Cloning of DNA fragments was achieved via restriction enzyme digestion, gel 
purification and ligation. Restriction enzyme digestions were performed according to 
manufacturers instructions (all enzymes were from Roche or NEB). Digested DNA 
was separated by running on agarose gels (0.6 – 1.5% depending on size of 
fragment) in TAE buffer.  The desired fragment was cut from the gel and the DNA 
extracted using Qiagen gel extraction kit (Qiagen) according to manufacturers 
instructions. The concentration of the recovered DNA was estimated by agarose 
electrophoresis. Ligations were performed with a 3:1 insert:vector molarity ratio with 
1U of T4 DNA ligase (Roche) in 1X T4 ligation buffer (Roche) and incubated at 16°C  
overnight.  
2.3.3. Transformation of competent cells 
A 200µl aliquot of competent cells was thawed on ice. Approximately 10ng of plasmid
 
DNA or ligation reaction was added in 1-3µl of dH2O, gently stirred and incubated on 
ice for 30 minutes. The tube was heated at 42°C for 1 minute and then cooled on ice 
for 2 minutes. 1ml of LB was added to the tube and incubated in a shaker at 37°C for 
1 hour. 50 to 300µl of the culture were plated on LB agar plates with appropriate 
selection and incubated at 37°C overnight.  
2.3.4. Analysis of transformants 
In order to check if a ligation has worked the following mini-prep protocol was used. 
Single colonies were used to inoculate a tube containing 3ml LB media with 
appropriate selection and incubated in a shaker at 37°C overnight. 1.5 ml of the 
culture was centrifuged at 13000rpm for 3 minutes and the supernatant was 
discarded. 150µl of solution I was added to the tube and it was vortexed to mix well. 
To lyse the cells, 150µl of
 
freshly prepared solution II was added and the tube was 
inverted 4-5 times to mix. To neutralise the lysate, 250µl of cold solution III was 
added and the tube was inverted 4-5 times to mix. The sample was then centrifuged 
at 13000 rpm for 15 minutes and the supernatant transferred to a clean tube.  To 
precipitate the DNA, 1ml of cold ethanol was added and the tube was inverted 4-5 
times to mix before incubating at -20°C for 30 minutes. The sample was then 
centrifuged at 13000rpm for 30 minutes to pellet the DNA, which was then dissolved 
in 50µl dH2O to give a final concentration of about 2.5µg/ml.
 
2.3.5. Preparation of plasmid DNA 
Qiagen mini-prep and midi-prep kits were used according to manufacturers 
instructions to prepare desired quantities of plasmid DNA.  
2.3.6. Isolation of genomic DNA 
Culture media was aspirated from ES cells and they were washed twice with PBS. 
Lysis buffer was added to the well (0.4ml per 2cm2 well) and plates were incubated at 
37°C overnight. The following day the lysate was transferred to an eppendorf tube 
and an equal volume of isopropanol was added. The tube was gently inverted a few 
times until the DNA was visible then the sample was centrifuged in a bench top 
centrifuge at 14000 rpm for 20 minutes at 4°C.   
2.3.7. Southern hybridisation 
20µg of genomic DNA were digested with 200 units of restriction enzyme in the 
appropriate buffer and temperature overnight. Digested DNA was precipitated by 
adding 3 volumes of ethanol (BDH) and 1/10 volume 3M Na Acetate and leaving at  -
20°C overnight. Samples were centrifuged at 14000rpm at 4°C for 30 mins then 
washed with 70% ethanol, before dissolving DNA in 20µl dH2O. The digested DNA 
was run on a 0.8% agarose gel in TAE buffer overnight. The gel was placed in 
depurination solution for 10 minutes (or until the bromophenol blue turned yellow) 
with gentle agitation then rinsed with dH2O. The DNA was denatured to allow its 
transfer to the membrane by placing the gel in denaturation solution for 30 minutes 
with gentle agitation. The gel was then blotted by capillary transfer onto a positively 
charged nylon membrane (Hybond N+, Amersham) overnight in denaturation 
solution. Following transfer the membrane was baked in an oven at 80°C for 2 hours. 
Then membrane was either stored in an air tight container at room temperature or 
used immediately for hybridisation. For hybridisation, the membrane was rinsed in 2X 
SSC and placed in a hybridisation tube with 30ml prehybridisation solution for 2 
hours to prevent non-specific binding. The radiolabelled probe was prepared by 
denaturing a solution containing 30ng of plasmid DNA fragment in 11µl
 
dH2O by 
boiling for 10 minutes and then chilling on ice for 5 minutes. Then added to the tube 
was 4µl of High Prime (Roche) and 5µl -32P-labelled dCTP (Amersham), and it was 
incubated at 37°C for 30 minutes before adding 2µl 0.2M EDTA and 28 µl STE buffer 
to stop the reaction. The sample was then put in a ProbeQuant G-50 Microcolumn 
(Amersham) and centrifuged at 300rpm for 2 minutes and the eluate containing the 
probe was reserved. Before adding the probe to the hybridisation solution it was 
denatured at 100°C for 10 minutes. The membrane was then incubated with 15 ml 
hybridisation solution containing the denatured probe in a rotating tube at 65°C 
overnight. The membrane was washed with 2X to 0.5X SSC with 0.1% SDS to 
remove non-bound radiolabelled probe and then the labelled target sequence was 
visualised using autoradiography (Kodak film).   
2.4. Cell culture 
Generally cells were grown in tissue culture plastics (Iwaki) coated with 0.1% gelatine 
(Sigma) and incubated in at 37°C with 7% CO2 in a humidified incubator (Sanyo). All 
solutions were sterility tested before use. To avoid bacterial and fungal 
contamination, all tissue culture manipulations were undertaken inside a laminar flow 
sterile hood (Microflow) and surfaces and objects were sprayed with 70% industrial 
methylated spirits (IMS) before use.   
2.4.1. Primary culture 
E14.5 midbrains were dissected, then were manually dissociated by trituration in 
GMEM media supplemented 100 U/ml penicillin (Invitrogen) and 100 µg/ml 
streptomycin (Invitrogen). Cells were plated at a density of 4x105 cells/ml and 
cultured on a layer of PA6 stromal cells (as described below) for 48 hours, then were 
fixed and processed for immunohistochemistry.  
2.4.2. PA6 stromal cell culture 
PA6 cells were cultured on 0.1% gelatine-coated tissue culture flasks in GMEM.  
2.4.3. Routine culture of ES cells 
ES cells were cultured on 0.1% gelatine-coated tissue culture flasks or plates in 
Glasgow modified Eagle’s medium (GMEM) supplemented with 100 units/ml 
leukaemia inhibitory factor (LIF). LIF was prepared in house by transfecting COS-7 
cells with a human LIF expression plasmid and harvesting the medium. The 
concentration of LIF was assayed using CP1 indicator cells (LIF preparation was 
performed by L. Taylor). All media and solutions were tested for contamination 3 
days before use. When passaging and thawing cells, all media and solutions were 
prewarmed to 37°C.  
2.4.3.1. Passaging ES cells  
To passage the cells the media was removed using an aspirator then cells were 
washed twice with PBS. 1X (0.025%) trypsin (Invitrogen) was added to just cover the 
cell monolayer and the flask was incubated at 37°C for about 1 minute. The trypsin 
activity was neutralised by addition of media, 4mls media was added for every 1ml of 
1X trypsin. The cell suspension was transferred to a universal tube and centrifuged 
for 5 minutes at 1200rpm. Cells were then resuspended in media to achieve a single 
cell suspension, counted using a haemocytometer and replated at a density of 106 
cells per 25cm2 flask. Routinely cells were passaged every 2-3 days.  
2.4.3.2. Freezing ES cells 
Cells in tissue culture flasks were trypsinised as before and centrifuged for 5 minutes 
at 1000rpm. Cells were resuspended in 1ml of freezing mix (10% dimethyl sulphoxide 
(DMSO) in normal culture media) per 25cm2 flask and transferred into a cryotube 
(Nunc) at 0.5ml per vial. Cryotubes were placed at -80°C overnight and then 
transferred to a liquid nitrogen cell bank (Series 2300, Custom biogenic Systems).  
To freeze cells in 24-well tissue culture plates (they should be 70% confluent), the 
media was removed and replaced with just enough freezing mix to cover the layer. 
The plate was then placed in a polystyrene box and stored at -80°C.  
2.4.3.3. Thawing ES cells 
Frozen cryotubes were retrieved from liquid nitrogen storage and placed immediately 
into 37°C waterbath. Once the cells were thawed they were transferred into 9.5 ml 
warm media to dilute out the DMSO. The cell suspension was then centrifuged for 5 
minutes at 1200rpm and then the cells were gently resuspended in 10mls of media 
and transferred to a 25cm2 flask. The media was then refreshed about 10 hours later 
to remove any dead cells and dilute out the remaining DMSO.  
To thaw frozen 24-well plates, pre-warmed media was added to fill the wells and the 
bottom of the plate was warmed by hand. Once thawed the media was carefully 
removed, leaving just enough to cover the layer of cells and 0.5ml fresh media was 
added.  
2.4.5. Diploid aggregation method 
The method used was based on that of Nagy and Rossant (Nagy and Rossant, 
1993). Briefly, eight-cell stage embryos were flushed from the oviducts of 2.5 days 
post-coitum (dpc) superovulated F1 females (PMS <48hrs 0.0 dpc, HCG 0.0 dpc). 
The zona pellucida was removed and they were incubated with small clumps of ES 
cells (8-15 ES cells per embryo) overnight. Embryos were then transferred to 2.5 dpc 
pseudopregnant F1 recipients, a maximum of 8-10 embryos were transplanted into 
each uterine horn.       
2.5. Gene targeting  
2.5.1. Transfection and selection of recombinant ES cells 
Three 150cm2 confluent flasks of E14TG2a ES cells at passage 12 were harvested 
by trypsinisation and pooled to give a total of 6x107 cells. At this stage 2x106 cells 
were plated on two 10cm plates as controls. The remaining cells were centrifuged for 
5 minutes at 1200rpm and resuspended in 700µl of PBS. The cells were transferred 
to a sterile electroporation cuvette and 50µg of linearised targeting vector DNA in 
100µl PBS was added. Cells were then electroporated at 800V and
 
3µF for 0.1 
seconds (BioRad Gene Pulser). Immediately after electroporation the cells were 
resuspended in media and plated on 18 10cm2 plates at a density of 2x106 cells per 
plate. 24 hours later HygromycinB was added to the plates at a concentration of 
100µg/ml (9 plates) and 150µg/ml (9 plates). Media with HygromycinB selection was 
refreshed every other day. When appropriate (about 10 days), single HygromycinB 
resistant colonies were picked into 24-well plates and expanded. Each clone was 
split into two 24-well plates, one of which was frozen and the other was used for 
genomic DNA extraction for Southern blotting.   
2.5.2. Transient Cre expression in ES cells 
A recombinant clone was expanded to a 25 cm2 flask and trypsinised as before. Cells 
were centrifuged for 5 minutes at 1200rpm and resuspended in 700µl of PBS. 
Transient Cre expression was achieved using a plasmid (pCAGCre) containing Cre 
under the control of the cytomegalovirus/chicken beta-actin (CAG) promoter, which 
produces efficient recombination by Cre (Araki et al., 1997). The cells were 
transferred to a sterile electroporation cuvette and 10µg of Cre plasmid (pCAGCre) in 
100µl of PBS was added. Cells were then electroporated
 
at 800V and 3µF for 0.1 
second (BioRad Gene Pulser). Immediately after electroporation the cells were 
resuspended in media and plated on six 10cm2 plates at a densities of 1x104 cells per 
plate (two plates), 3x103 cells per plate (two plates) and 1x103 cells per plate (two 
plates). After 48 hours, ganciclovir selection was added to the plates at a 
concentration of 2.5µM. Media with ganciclovir selection was refreshed every other 
day. When appropriate (about 10 days), single ganciclovir resistant colonies were 
picked into two 24-well plates (one to freeze and one to extract DNA for Southern 
blot) and expanded.                    
Chapter 3  
Pitx3-GFP mirrors Pitx3 RNA and protein expression  
3.1. Introduction 
In order to visualise and follow the expression of Pitx3, a reporter protein was linked 
to the endogenous expression of Pitx3. Reporter proteins can generally be visualised 
due to bioluminescence, fluorescence or enzymatic properties. The gene encoding 
the reporter protein (the reporter gene) may be expressed under the control of a 
specific promoter by a number of methods, for example, in a traditional transgenic 
approach a construct can be made containing a cell type-specific promoter fused to a 
reporter gene. The DNA construct containing the promoter and reporter gene is 
directly injected into one of the pronuclei of a single celled zygote and the DNA 
integrates stably into the genome. However, this integration is random and 
neighbouring sequences may interfere with the regulation of the reporter gene 
expression. These position effects can obscure analysis of reporter gene expression, 
therefore, this approach is not the most reliable for analysing gene expression. To 
avoid this problem, the reporter gene may be placed under the control of a promoter 
of an endogenous gene via homologous recombination in ES cells. The main 
advantage of this knock-in approach is that the reporter gene is under the control of 
the complete set of endogenous cis–acting regulatory elements that control the 
endogenous gene expression.   
A number of proteins have been successfully used as reporter proteins, these include 
the enzymes -galactosidase ( -gal) and luciferase. Enzymatic reporters are 
sensitive detectors of gene expression as each molecule of enzyme can catalyse 
many reactions to produce the detected product. However, a substrate must be 
present in order to facilitate the visualisation of the reporter expression and it can be 
difficult to deliver the substrate to live cells. Another option is the use of a vital 
fluorescent reporter such as green fluorescent protein (GFP) from the jellyfish 
Aequorea victoria. Several mutants of wild-type GFP have been created to allow 
increased brightness, thermostability, optimised codon usage for mammalian 
expression and different spectral properties. For example, the most commonly used 
variant eGFP has two amino acid changes in the vicinity of the fluorophore (Phe-64 
to Leu and Ser-65 to Thr), thus it is codon optimised and is 35-fold brighter than wild-
type GFP (Hadjantonakis et al., 2003). Whilst eGFP may not be as sensitive as some 
enzymatic reporters it has many advantages including visualisation in both live and 
fixed tissues and cells, no substrate or reaction cofactors are required and 
commercial antibodies are available. Thus, eGFP was the reporter protein of choice 
in the making of Pitx3 reporter mice.  
Prior to the start of this PhD thesis, mice were created with an enhanced GFP 
(eGFP) reporter targeted into the Pitx3 locus via homologous recombination in ES 
cells. The entire Pitx3 coding sequence (exons 2, 3 and 4) was replaced with an 
eGFPirespac cassette downstream of the endogenous Pitx3 promoter (Fig. 3.1) 
(Zhao et al., 2004).  Therefore, eGFP expression is under the control of endogenous 
Pitx3 regulatory elements and there is no expression of Pitx3 from the mutated allele. 
Mice that are heterozygous and homozygous for this Pitx3-GFP allele have been 
generated from these ES cells and they are both viable, able to survive to adulthood 
and fertile. In addition, Pitx3-heterozygous mice have no apparent phenotypic 
abnormality (see Ch. 5). The first aim of this study was to investigate whether the 
expression of the Pitx3-GFP reporter faithfully mirrors that of reported Pitx3 
expression in mouse embryos and in the adult mDA system.    
3.2. Results  
3.2.1. Direct visualisation of Pitx3-GFP in heterozygous embryos 
Previous studies reported that Pitx3 mRNA was expressed in the eye lens, 
midbrain, tongue, incisor primordia, mesenchyme around the sternum and 
vertebrae and in the head muscles (Semina et al., 1998; Smidt et al., 1997). To 
investigate whether the expression of the Pitx3-GFP reporter replicated Pitx3 
expression, GFP was visualised in phenotypically normal Pitx3-heterozygous 
embryos. Embryos between the ages E10.5 and E14.5 were either taken 
immediately for whole mount visualisation or fixed and sectioned at 100µm
 
on a 
vibratome (Ch. 2.2). In the brain, Pitx3-GFP expression was confined to the ventral 
midbrain and was first visible at E12.5 as a small domain on the ventral 
mesencephalic flexure (Fig. 3.2. A). From E12.5 to E13.5 there is a significant 
increase in the Pitx3-GFP expressing domain in the ventral midbrain (Fig. 3.2. B). At 
E14.5 Pitx3-GFP expression can be observed in the cell bodies of ventral midbrain 
neurons and also in their axons projecting to their target sites in the striatum and 
basal forebrain (Fig. 3.2. C). Pitx3-GFP expression was also present in the lens, 
where it could be first detected at E10.5 in the lens primordium (Fig. 3.3. A) and 
expression remained in the lens throughout life (Fig. 3.3. B). In addition, Pitx3-GFP 
expression was visible in the somites (Fig. 3.3. C), cranial facial muscles and the 
tongue (Fig. 3.3. D).   
3.2.2. Pitx3-GFP mirrors Pitx3 protein expression 
Direct visualisation of the GFP reporter described above established that Pitx3-GFP 
was expressed in the area where mDA neurons arise and where Pitx3 expression 
had been reported previously. To directly demonstrate that Pitx3-GFP expression 
reports that of Pitx3 protein expression in mDA neurons, Pitx3 antibody staining was 
performed along with antibody staining for GFP on Pitx3-heterozygous midbrains at 
E12.5. In all Pitx3 hetrozygous midbrain sections studied, the Pitx3-GFP expressing 
cells were also positive for Pitx3 antibody and vice-versa (Fig. 3.4). This confirms that 
the Pitx3-GFP reporter accurately replicates Pitx3 protein expression in mDA 
neurons. Therefore, Pitx3-GFP could be used as a lineage marker to track the fate of 
Pitx3-expressing cells in both the Pitx3 heterozygous and Pitx3 null mice.  
3.2.3. Pitx3 is expressed exclusively in mDA neurons of adult mice 
Continued expression of Pitx3 in mDA neurons in adulthood has been reported 
before and during the course of this study (Hwang et al., 2003; Smidt et al., 2004; 
Smidt et al., 1997; Van Den Munckhof et al., 2003). To validate the expression of the 
Pitx3-GFP reporter in adult mDA neurons, sections of adult midbrain were stained 
with antibodies against GFP and TH (Fig. 3.5). Counting of labelled cells in eight 
randomly chosen fields in the SNc and VTA of three adult brain samples revealed 
that the vast majority of TH-expressing cells express Pitx3-GFP and vice-versa 
(Table 3.1).  This was the case in both the SNc and in the VTA. In the SNc 98.53 ± 
2.35 of TH+ cells expressed Pitx3-GFP and 99.36 ±0.9% of Pitx3-GFP+ cells 
expressed TH. Similarly 94.6 ± 8.5% of TH+ cells in the VTA expressed Pitx3-GFP 
and 94.9 ± 6.4% of Pitx3-GFP+ cells expressed TH. The few cells that did not appear 
to co-express Pitx3 and TH were not localised in any region and were scattered 
throughout the SNc and VTA. A possible reason for the detection of some Pitx3- or 
TH-only expressing cells may be due to the plane of the section, as the TH is 
localised to the cytoplasm whereas GFP is present in the nucleus and the cytoplasm.   
 
Number of cells 
counted 
% of TH expressing 
Pitx3-GFP 
% of Pitx3-GFP 
expressing TH 
SNc 884 98.53 ± 2.3 99.36 ±0.9 
VTA 457 94.6 ± 8.5 94.9 ± 6.4 
Table 3.1. Quantitative analysis of co-expression of Pitx3-GFP and TH in adult 
mDA neurons 
Data was collected from eight randomly chosen fields from three adult brain samples. 
Values are mean ± standard deviation.   
3.3. Summary 
The examination of embryos and adult mice heterozygous for the Pitx3-GFP allele 
revealed that Pitx3-GFP was an accurate reporter of Pitx3 expression. In embryos 
Pitx3-GFP expression was observed in midbrain, eye, somites, cranial facial muscles 
and the tongue, which correlates with reported sites of Pitx3 mRNA expression 
(Semina et al., 2000; Semina et al., 1997; Smidt et al., 1997).  Immunostaining with 
an antibody against Pitx3 was performed in conjunction with an antibody against 
GFP which revealed that Pitx3-GFP accurately mirrors Pitx3 protein expression in 
E12.5 Pitx3 heterozygous midbrain. Furthermore, in adult mice Pitx3-GFP was found 
to be co-expressed with TH in virtually all mDA cells of the SNc and VTA.  
 
Figure 3.1. Targeting of the Pitx3 locus to produce Pitx3-GFP. 
Shown at the top is the Pitx3 targeting vector which contains an engrailed 2 splice 
acceptor (SA), an eGFP reporter, an internal ribosomal entry site (IRES) and a 
puromycin resistance gene (pac)-polyA cassette. In addition, a floxed 
phosphoglycerate kinase (PGK) promoter-driven hygromycin-thymidine kinase 
(HygroTK) cassette is included to allow for selection of ES cell transfectants and is 
later removed via Cre-mediated recombination. The 5’ homologous arm is 1.8kb and 
the 3’ homologous arm is 6kb. The homologous areas are indicated and so is the 
targeted locus following a replacement homologous recombination event. Cre-
mediated excision of the PGK-HygroTK cassette results in the final targeted locus. 
The four boxes represent Pitx3 exons and the filled regions indicate coding 
sequence, whilst the blank regions represent non-coding sequence.  
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Figure 3.2. Direct visualisation of Pitx3-GFP in the CNS of Pitx3 heterozygous 
embryos. 
Whole mount or 100µm vibrotome sectioned embryos were used to reveal the 
expression of Pitx3-GFP. Pitx3-GFP expression is first seen in the midbrain at E12.5 
and appears as a small group of cells on the ventral surface of the mesencephalic 
flexure (A). By E13.5 this group of Pitx3-GFP expressing cells in the midbrain is 
larger (B). A ventral view of a whole E14.5 midbrain shows the cluster of Pitx3-GFP 
cells in the ventral midbrain and projections towards their forebrain targets (C). 
 
Figure 3.3. Direct visualisation of Pitx3-GFP in non-CNS areas of Pitx3 
heterozygous embryos. 
A significant non-CNS site of Pitx3 expression is the lens where Pitx3-GFP 
expression is visible in the lens primordium at E10.5 (A) and in the lens at E12.5 (B). 
Additionally Pitx3-GFP expression was detected in the somites at E12.5 (C) and in 
the tongue and head mesenchyme at E12.5 (D). 
 
Figure 3.4. Immunostaining for Pitx3 and Pitx3-GFP on E12.5 midbrain 
sections. 
Antibodies against Pitx3 and GFP were used on 30µm E12.5 midbrain sections. All 
Pitx3-GFP positive cells (green) are also positive for Pitx3 antibody (red) and vice-
versa. Panel shows x20 magnification (A-C) and x40 magnification (D-F). Scale bars 
200µm.
 
Figure 3.5. Co-expression of Pitx3-GFP and TH on adult midbrain sections. 
Examples of mDA neurons in SNc (A-C, G-I) and VTA (D-F, J-L) from adult midbrain 
30µm coronal sections stained with antibodies against GFP and TH. In both the SNc 
and VTA approximately all Pitx3-GFP+ cells (green) also express TH (red) and vice-
versa. There was the occasional cell that did not co-express Pitx3 and TH, examples 
of these are indicated by arrows pointing to Pitx3-GFP+ only cells (D) and TH+ only 
cells (E). Scale bars 100µm.    
Chapter 4  
Identification of ontogenetically distinct subgroups of 
mDA neurons   
4.1. Introduction 
The reported expression of Pitx3 mRNA in the midbrain begins at E11.5 (Smidt et al., 
1997), Pitx3 protein can be detected from E12.5 (Ch. 3) in mDA neurons and the 
espression of Pitx3 in mDA neurons continues into adulthood. The expression of TH 
in mDA neurons begins at around E11.5 (Foster et al., 1988; Solberg et al., 1993; 
Zetterstrom et al., 1997) and the presence of this key enzyme in dopamine synthesis 
is indicative of a dopaminergic phenotype. Between researchers there are differing 
definitions of the features that identify a dopaminergic neuron and a dopaminergic 
neuron progenitor. However, throughout this thesis a dopaminergic neuron will be 
defined as one that expresses TH. In addition, a post-mitotic neuron that is destined 
to become a mDA neuron but has not yet started to express TH will be described as 
a post-mitotic mDA neuron progenitor. Until now studies relating to the co-expression 
of Pitx3 and TH in early mDA neuron development had not been conducted. 
Therefore, it was not clear whether the earliest Pitx3-expressing cells were 
dopaminergic neurons (i.e. TH-positive) or non-dopaminergic (i.e. TH-negative) cells 
that will become mDA neurons. To address this issue, the pattern of Pitx3 and TH 
expression in the ventral midbrain from E12.5 to E14.5 was examined. These stages 
were chosen because the majority of mDA neurons emerge between E12.5 and 
E14.5 (Altman and Bayer, 1981; Hanaway et al., 1971; Lauder and Bloom, 1974) and 
the first stage at which Pitx3-GFP expression can be detected is E12.5 (Ch. 3.2).         
4.2. Results  
4.2.1. Analysis of Pitx3-GFP and TH expression in the developing 
midbrain at E12.5, E13.5 and E14.5 
Serial midbrain sections spanning the Pitx3 and TH expression domain from Pitx3-
heterozygous mice were stained with antibodies against GFP and TH. The Pitx3-
GFP reporter could be exploited in this situation to detect Pitx3 expression as the 
Pitx3 heterozygous mice were shown to be phenotypically normal (Ch. 5.2). The 
earliest stage examined was E12.5 as this was the first stage at which Pitx3-GFP 
expression could be detected in the midbrain. This revealed that Pitx3-GFP and TH 
were differentially expressed in some midbrain cells and co-expressed in other 
midbrain cells at E12.5.  Some cells express TH but not Pitx3, whilst another 
population of cells express Pitx3 but not TH and some cells express both TH and 
Pitx3. At the most rostral level of the E12.5 midbrain, the Pitx3-GFP and TH 
expression domains are in a relatively lateral position and at the most caudal level 
however, these domains are positioned relatively medially (Fig. 4.1).  Rostrally, the 
Pitx3+TH- population of cells is in a more lateral position relative to the Pitx3-TH+ 
expressing population (Fig. 4.1 A-B). Moving caudally, the Pitx3-GFP and TH 
expression domains remain partially overlapped and the Pitx3+TH- population is more 
ventral and lateral relative to the Pitx3-TH+ population (Fig. 4.1 C-F). Further 
caudally, the Pitx3-GFP and TH expression domains overlap more so there are more 
Pitx3+TH+ cells (Fig. 4.1 G-H). At this caudal position the Pitx3-GFP and TH 
expression domains resemble the VTA.  
At E13.5, a large proportion of cells are positive for both Pitx3 and TH expression 
and there are more of both Pitx3-GFP+ and TH+ cells compared to E12.5 (Fig.4.2). 
This suggests that many of the cells that expressed only Pitx3-GFP or TH at E12.5 
have now acquired TH or Pitx3-GFP expression, respectively. By E14.5, there are 
greater numbers of Pitx3-GFP+TH+ cells as compared to E13.5 and almost all mDA 
cells express both Pitx3-GFP and TH (Fig. 4.3) with the exception of some cells in 
the rostral lateral primordium, which still express only Pitx3-GFP (Fig. 4.3). By E14.5 
the collection of mDA neurons resembles that of the adult SNc and VTA and the few 
Pitx3+ cells that do not express TH are located in lateral most part of the primitive 
SNc. Eventually, by adulthood virtually all mDA neurons of the SNc and VTA express 
both Pitx3-GFP and TH (Ch. 3.3).   
4.2.2. Characterisation of Pitx3-GFP cells at E12.5 
At E12.5 many of the Pitx3-GFP expressing cells do not express TH. To investigate 
whether these cells are likely to be mDA progenitors, further immunohistochemical 
analysis was carried out on these cells at E12.5. Markers for mitotic progenitors 
(Ki67, labels cells in G1, G2 and M phase), nascent neurons ( Tubulin3), midbrain 
dopaminergic neurons and their progenitors (En1), GABAergic neurons (GAD) and 
glial cells (S100
 
and GFAP) were examined. Antibody staining for the neuronal 
marker Tubulin3 revealed that the majority of Pitx3-GFP cells were neurons (Fig. 
4.4). Some medially positioned Pitx3-GFP cells did not express Tubulin3, which 
may be due to their recent exit from the cell cycle and consequently they have not yet 
begun to express this neuronal marker. None of the Pitx3-GFP expressing cells 
expressed the proliferative marker Ki67 (Fig. 4.4), suggesting that all Pitx3-GFP cells 
are post-mitotic. As the main wave of neurogenesis in mouse occurs from around 
E13 and is followed by gliogenesis from around E17, it is not expected that the Pitx3-
GFP cells at E12.5 will express glial cell markers. The expression of  the early glial 
cell marker S100 begins at E13.5 in mouse brain restricted to the medulla and 
spinal cord (Vives et al., 2003) and glial fibrillary acidic protein (GFAP) protein is first 
detected in the mouse brain at E17 (Andrae et al., 2001). These markers, S100  and 
GFAP, were not observed in any Pitx3-GFP expressing cells at E12.5 (data not 
shown), suggesting that all Pitx3-GFP cells are neurons or neuron progenitors. Key 
evidence that the Pitx3-GFP cells actually are mDA progenitors is that the majority of 
Pitx3-GFP expressing cells also expressed En1 (Fig. 4.4), which is an early mDA 
marker expressed in all mDA neurons from early development through into adulthood 
(Simon et al., 2001). Other midbrain neuronal subtype markers for example glutamic 
acid decarboxylase (GAD) a marker for GABAergic neurons was not found to be 
expressed in Pitx3-GFP cells (Fig. 4.4). Taken together, these data suggest that at 
E12.5 the Pitx3-GFP positive cells are post-mitotic mDA neuron progenitors.   
4.2.3. Migration pattern of mDA neurons 
At E12.5 it is difficult to assess which cells will form the SNc and which will form the 
VTA as the structure formed by the Pitx3+ and TH+ cells in the midbrain does not 
accurately represent the adult SNc and VTA. Therefore, in order to understand more 
about the situation and likely fate of the midbrain cells at E12.5 it is useful to 
understand their migration pattern. Presently the data available on migration patterns 
of these neurons is ambiguous and there are different opinions on the true mode of 
migration (see Ch. 8.5). To estimate the likely migration pattern of these early mDA 
neurons, their orientation at E12.5 was examined. The bipolar orientation of the TH+ 
cells at E12.5 revealed that cells located closer to the medial part of the 
neuroepithelium exhibited a vertical orientation (Fig 4.5.B), suggestive of a vertical 
migration route. Whereas cells located in a lateral position had a more horizontal 
orientation (Fig. 4.5.C), suggestive of a horizontal migration route. This data points to 
a pattern of migration which involves the cells migrating down the midline first 
ventrally from the neuroepithelium, then horizontally towards the lateral areas of the 
mDA region.   
4.5. Summary 
Studies on TH and Pitx3 expression throughout the midbrain in early stages of mDA 
neuron generation have revealed that at E12.5 there are distinct subpopulations of 
mDA neurons with different TH and Pitx3 expression profiles.  Some mDA neurons in 
the midbrain at E12.5 express TH but not Pitx3, whilst another population of cells 
express Pitx3 but not TH and these two populations of cells partially overlap so that 
some cells express both TH and Pitx3. The Pitx3+TH- cells are generally located in a 
relatively more lateral and ventral position, which suggests that they represent a 
developing SNc. However, as development progresses more midbrain cells express 
both TH and Pitx3 and by adulthood virtually all mDA cells that express TH also 
express Pitx3 and vice versa. The midbrain cells that express Pitx3 at E12.5 are 
likely to be post-mitotic mDA progenitors as they express markers for nascent 
neurons ( Tubulin3) and midbrain dopaminergic neurons and their progenitors (En1). 
In addition, these Pitx3-expressing cells do not express markers for mitotic 
progenitors (Ki67), glial cells (S100
 
and GFAP) or GABAergic neurons (GAD). The 
bipolar orientation of the mDA cells at E12.5 is suggestive of a migration pattern 
vertically downwards from the midline of the neuroepithelium before lateral migration 
to their final position in the midbrain.  
 
Figure 4.1. Series of sections through an E12.5 Pitx3 heterozygous midbrain. 
Rostral to caudal coronal E12.5 midbrain sections stained with antibodies against 
GFP and TH (A-H). In the rostral sections the Pitx3-GFP and TH expression domains 
are in a relatively lateral position, however the Pitx3+TH- population of cells is in a 
more lateral position relative to the Pitx3-TH+ expressing population (A-B). More 
caudally, the Pitx3+TH- population is more ventral and lateral relative to the Pitx3-TH+ 
population (C-F). Further caudally, the Pitx3-GFP and TH expression domains are 




Figure 4.2. Series of sections through an E13.5 Pitx3 heterozygous midbrain. 
Rostral to caudal coronal E13.5 midbrain sections stained with antibodies against 
GFP and TH (A-G). Many of the cells in these sections are Pitx3+TH+. In the rostral 
sections the cells are located in a relatively lateral position with some Pitx3+TH- cells 
in a ventral position relative to the Pitx3-TH+ cells (A-C). More caudally the majority of 




Figure 4.3. Series of sections through an E14.5 Pitx3 heterozygous midbrain. 
Rostral to caudal coronal E14.5 midbrain sections stained with antibodies against 
GFP and TH (A-F). The majority of the cells are Pitx3+TH+ at this stage, however 
some Pitx3+TH- cells remain in a relatively lateral position in the rostral most sections 
(A-B). Scale bar is 200µm. 
GFP/TH
 
Figure 4.4. Immunohistochemical characterisation of E12.5 Pitx3-GFP cells. 
Coronal midbrain sections from E12.5 Pitx3 heterozygous embryos were 
immunostained with anti-GFP (green, left panel) combined with either anti-ßTubulin3, 
Ki67, GAD or En1 (red, middle panel) antibodies, merged image is shown in the right 
panel. All images show the left side of the section, in which the ventricular zone is at 
the top right of the image. Scale bar is 100µm. 
 
Figure 4.5. Migration pattern of E12.5 mDA neurons.   
Sections from E12.5 midbrain were immunostained for TH. Boxed areas in panel (A) 
at higher magnification show the medial DA cells displaying vertical orientation (B) 
and the lateral DA cells displaying horizontal orientation (C). Scale bars are 100 µm 
for panel (A) and 25 µm for panels (B) and (C).
              
Chapter 5  
Phenotype of Pitx3 knockout mice in development and 
adulthood  
5.1. Introduction 
A valuable approach to understanding the functional significance of a gene is to 
generate mice which lack the gene product and analyse their phenotype. As 
described in Ch. 3.1, mice have been generated in which the entire Pitx3 coding 
sequence has been replaced by a GFP reporter via homologous recombination 
(Zhao et al., 2004). In Pitx3 heterozygous mice the Pitx3-GFP reporter was used to 
confirm the mDA neuron restricted expression of Pitx3 in the CNS and reveal that 
virtually all adult SNc and VTA mDA neurons express Pitx3 (Ch. 3.2). The specific 
expression of Pitx3 in mDA neurons in the CNS and the fact that it is a homeodomain 
containing transcription factor make Pitx3 a potential candidate to play a role in mDA 
neuron development. To investigate this potential role of Pitx3, mice homozygous for 
the Pitx3-GFP mutation (i.e. Pitx3 null) have been bred and they are viable and 
fertile. The only obvious abnormality with the Pitx3 null mice is that they have no 
eyes due to the crucial role of Pitx3 in lens development (Rieger et al., 2001; Semina 
et al., 2000). In order to investigate the mDA neuron phenotype of the Pitx3 null mice 
three stages of development were studied in detail: E12.5 was the earliest stage 
looked at as this was the first time point at which Pitx3 protein could be detected. The 
next stage examined was 2 days later at E14.5, at this stage the structure formed by 
the mDA cells is recognisable as the SNc and VTA primordium. Finally, the adult 
midbrain of Pitx3 null mice was assessed.  
During the course of this study a number of papers were published describing the 
phenotype of the naturally occurring mouse mutant aphakia (Hwang et al., 2003; 
Nunes et al., 2003; Smidt et al., 2004; Van Den Munckhof et al., 2003). Aphakia is a 
spontaneously occurring recessive phenotype that is associated with a double 
genomic deletion in the Pitx3 gene. The aphakia homozygous mouse was 
characterised by small eyes with no lens due to lack of lens development beyond 
E11, the lens stalk stage (Varnum and Stevens, 1968; Zwaan, 1975).  More 
recently, a deletion in the Pitx3 promoter region (Semina et al., 2000) and a deletion 
in the gene itself, eliminating the non-coding exon 1 and part of intron 1 (Rieger et 
al., 2001) have been identified as the cause of abnormal ocular development in the 
aphakia mouse.  Aphakia mice have a 652bp deletion 2.5kb upstream from the 
putative Pitx3 transcription start site and a 1423bp deletion that removes non-
coding exon 1 and the putative Pitx3 promoter region in intron 1 (Rieger et al., 2001; 
Semina et al., 2000).  The studies on the midbrain phenotype of aphakia mice have 
shown that adult aphakia mice have a loss of TH-expressing cells in the SNc, 
whereas the VTA is relatively intact.  The striatum of aphakia mice also displayed a 
loss of TH immunoreactivity and this was restricted to the dorsal striatum, which is 
the target structure for projections from the SNc (Hwang et al., 2003; Nunes et al., 
2003; Smidt et al., 2004; Van Den Munckhof et al., 2003).  Examination of earlier 
stages in mDA development of aphakia mice has lead to conflicting results. One 
study reported an altered distribution of TH-expressing cells in E12.5 aphakia mice, 
although the total number of TH-expressing cells does not appear to be reduced 
(Smidt et al., 2004). However, another study found no changes in TH expression in 
E12.5 aphakia midbrain as compared to wild type (Van Den Munckhof et al., 2003). 
These results indicate that Pitx3 does have a role in mDA neuron development, 
especially in the SNc. However, the discrepancies between the aphakia studies as 
to the timing and localisation of the deficit in mDA neurons along with the lack of 
quantitative data make it difficult to derive the true function of Pitx3 in mDA neurons. 
Additionally, as the aphakia mutation affects the promoter regions of the Pitx3 gene 
and the entire coding sequence of Pitx3 remains intact, it is unclear whether the 
phenotype of the aphakia mice fully reflects the requirement for Pitx3 in mDA 
neuron development. Consequently, a study of a true Pitx3 null mouse line with a 
deletion of the entire Pitx3 coding sequence is required to evaluate the function of 
Pitx3 in mDA neurons.   
5.2. Results  
5.2.1. Nascent mDA neurons are absent in Pitx3 null mice 
Firstly, the numbers of TH+ neurons in E12.5 Pitx3 heterozygous and wild-type 
embryos were compared, by counting the numbers of TH+ neurons in serial sections 
from 5 embryos of each genotype.  The average number of TH+ neurons in Pitx3 
heterozygous and wild-type embryos were very similar at 1814±469 and 1870±293, 
respectively (Table 5.1). This result and observations in adult Pitx3 heterozygous 
mice (see below) indicate that the heterozygous mutation does not affect mDA 
neuron development or survival. Thus Pitx3 heterozygous mice can be used as a 
control allowing the GFP reporter to be exploited in determining the fate of the Pitx3-
GFP expressing neurons in Pitx3 null mice.  
As described previously in Ch. 4.2.1 the Pitx3 heterozygous E12.5 mouse 
mesencephalon contains cells expressing both Pitx3 and TH as well as cells that 
express only one of these markers (i.e. Pitx3-GFP+TH- and Pitx3-GFP+TH- cells) (Ch. 
4.2). Quantitative analysis of E12.5 Pitx3 heterozygous and Pitx3 null embryos was 
performed by counting all labelled cells in serial coronal sections (20µm thick) of an 
entire midbrain (Fig. 5.1). Total counts from four or five E12.5 embryos of each 
genotype were averaged and standard deviations were calculated (see Ch. 2.2.7). 
This revealed that there was no significant difference in the number of Pitx3-GFP+TH- 
cells at E12.5 (Table 5.1) suggesting that Pitx3 is not required for the generation or 
maintenance of the Pitx3-GFP+TH- mDA neuron progenitors. However, there was a 
loss of around half of the Pitx3-GFP+TH+ cells in the E12.5 Pitx3 null mice (628±362) 
as compared with Pitx3 heterozygous (1211 ± 316) (Table 5.1). Also there was a 
reduced number of total mDA neurons in E12.5 Pitx3 null mice (834 ± 419) compared 
to Pitx3 heterozygous mice (1814±469) and a significant decrease in the number of 
Pitx3-GFP-TH+ cells in the Pitx3 null (237±126) as compared to Pitx3 heterozygous 
mice (605 ± 234) (Table 5.1). Since it is the total TH+ cells (both the Pitx3-GFP-TH+ 
and Pitx3-GFP+TH+ cells) rather than the Pitx3-GFP+TH- cells that are lost in the 
Pitx3 null mice, this data indicates that Pitx3 is necessary for the generation or the 
maintenance of nascent mDA neurons.   
5.2.2. Pitx3 is required for TH expression in SNc neurons 
The lack of TH expression in only some Pitx3-GFP expressing cells in the Pitx3 null 
mice at E12.5 suggests that Pitx3 is not necessary for correct TH expression in all 
mDA neurons, but that the requirement for this function of Pitx3 may display cell 
type-specificity. If this is the situation then it would be expected that the deficiency in 
TH expression would be restricted to particular sub-regions of the Pitx3 null midbrain.  
To investigate this, E14.5 brains were studied as at this stage the VTA and SNc 
primordium become recognisable.    
In contrast to the situation at E12.5, by E14.5 the majority of mDA cells are 
Pitx3+TH+. E14.5 midbrain sections double stained with antibodies against TH and 
GFP revealed a specific loss of TH expression in the developing SNc of the Pitx3 null 
mice when compared to Pitx3 heterozygous mice (Fig. 5.2). Quantitative analysis 
showed that the loss of TH expression in Pitx3-GFP cells was restricted to the SNc, 
with 53 ± 8% of Pitx3-GFP cells expressing TH in Pitx3 null mice compared to 88 ± 
5% in Pitx3 heterozygous mice (Fig 5.3), whereas the percentage of Pitx3-GFP cells 
expressing TH in the VTA was approximately the same in Pitx3 null (84 ± 17%) and 
Pitx3 heterozygous (81 ± 14%) mice (Fig 5.3). As expected from the deficiency in TH 
expression in the SNc of Pitx3 null mice, there were a greater number of Pitx3-
GFP+TH- cells in the SNc of Pitx3 null (519±15.3) as compared to Pitx3 heterozygous 
(189±7.9) (Table 5.1, Figure 5.2).  The total midbrain counts of  Pitx3-GFP 
expressing and TH expressing cells revealed that there was no significant difference 
in the numbers of Pitx3-GFP-TH+ cells or Pitx3-GFP+TH+ cells between Pitx3 
heterozygous and Pitx3 null mice (Table 5.1).  It is likely that the large numbers of 
VTA cells mask the SNc effect on the cell numbers. However, from the total midbrain 
counts it was possible to detect significantly higher numbers of Pitx3-GFP+TH- cells 
in Pitx3 null mice (6773±1356) as compared to their heterozygous littermates 
(1834±341) (Table 5.1). This data demonstrates the requirement for Pitx3 for the 
maintenance and/or initiation of TH expression in a subset of mDA neurons.  
5.2.3. The loss of mDA neurons is restricted to SNc neurons  
As well as a lack of TH expression, there was a deficiency of over half of the Pitx3-
GFP+TH+ cells in the SNc of the Pitx3 null (596±11.3) as compared to Pitx3 
heterozygous littermates (1415±43.7) (Table 5.1). Additionally, to a much lesser 
degree than in the SNc, there was some loss of Pitx3-GFP+TH+ cells in the VTA of 
the Pitx3 null mice (813±19.9) as compared to heterozygous littermates (1161±25.3) 
(Table 5.1).  This indicates that Pitx3 is required for the survival and/or maintenance 
of Pitx3+TH+ cells in the SNc.  
These results reveal that two elements likely contribute to the reduction in the 
number of DA neurons (TH expressing cells) in the SNc of E14.5 Pitx3 null mice. 
One element is the failure of TH expression in some Pitx3-GFP expressing cells and 
the other is the loss of Pitx3-GFP+TH+ cells.    
  
Table 5.1. Quantitative analysis of E12.5 and E14.5 mesencephalic DA cells in 
wildtype, Pitx3 heterozygous and Pitx3 null mice 
E12.5 and E14.5 total results were obtained from the counting of all labelled cells in 
serial sections from three embryos for each genotype, and the numbers of cells from 
each section were summed. E14.5 SNc and VTA results were obtained from five 
midbrain sections from three embryos for each genotype. 
(a, Student t-test between Pitx3+/-  and Pitx3-/-; b, Student t-test between Pitx3 wt  
and Pitx3+/-; n/a, not applicable; n, number of embryos)   
5.2.4. Progressive loss of mDA neurons results in the absence of SNc 
mDA neurons in Pitx3 null adult mice 
Adult midbrain and striatum were immunostained with antibodies against TH alone 
and this showed that Pitx3 heterozygous and wild type littermates have a comparable 
number of TH expressing cells, which, along with the data from E12.5 mice (Table 
5.1), confirms that mDA neurons in Pitx3 heterozygous mice appear to be 
phenotypically normal. However, in the Pitx3 null midbrain there is a considerable 
loss of TH expressing cells in the SNc, whilst the VTA is relatively intact (Fig. 5.4). 
This implies that the loss of mDA neurons observed in the SNc at E14.5 progresses 
to result in a complete loss of mDA neurons in adulthood. Examination of Pitx3 
heterozygous and Pitx3 null midbrains for Pitx3-GFP and TH expression revealed 
Age Genotype GFP+TH- GFP-TH+ GFP+TH+ Total TH+ 
Pitx3 wt  (n=4) n/a n/a n/a 1870±293 
Pitx3+/-   (n=5) 608±378 605±234 1211±316 1814±469 
Pitx3-/-    (n=5) 809±264 237±126 628±362 834±419 
E12.5 
P<= 0.35a 0.027a 0.029a 0.84b 
Pitx3+/-   (n=3) 1834±341 4364±629 17622±4397  
Pitx3-/-    (n=3) 6773±1356 4068±279 14175±3600  
E14.5 
total 
P<= 0.004 1 1  
Pitx3+/-   (n=3) 189±7.9 211±25.8 1415±43.7  
Pitx3-/-    (n=3) 519±15.3 108±5.7 596±11.3  
E14.5 
SNc 
P<= 2.733x10-5 0.2331 4.363x10-5  
Pitx3+/-   (n=3) 272±29.8 123±15 1161±25.3  
Pitx3-/-    (n=3) 150±16.1 160±10.7 813±19.9  
E14.5 
VTA 
P<= 0.2698 0.5344 0.003417  
that the loss of TH expression was mirrored by a loss of Pitx3-GFP expression in 
Pitx3 null mice, resulting in a complete loss of Pitx3-GFP+TH+ cells in the SNc (Fig. 
5.5). Although the possibility that Pitx3 is required to regulate its own expression 
cannot be ruled out, the fact that both TH and Pitx3-GFP expressing cells are lost in 
the SNc suggests that these cells actually die rather than just down-regulate TH and 
Pitx3 expression. Further evidence for cell loss is presented in Chapter 6.  
Axons from the SNc and VTA project to different target structures in the striatum. The 
SNc mDA neurons project to the dorsolateral striatum known as the caudate 
putamen, whereas the VTA mDA neurons project to the ventromedial striatum, 
nucleus accumbens and olfactory tubercle. The mDA neuron afferents in the striatum 
are the major source of TH immunoreactivity in the striatal target areas of the VTA 
and SNc neurons. The existence of intrinsic TH-positive neurons in the striatum has 
been reported, however, the presence of these cells is controversial and if valid there 
are likely to be relatively few cells (Baker et al., 2003; Cossette et al., 2004). To 
determine whether the mDA projections from the SNc and VTA are intact and 
innervating the correct areas in Pitx3 null mice, the striatal DA afferents were 
examined for the presence of TH. In the Pitx3 heterozygous and wild type striatum 
TH antibody staining is present throughout the caudate putamen, nucleus 
accumbens and olfactory tubercle (Fig. 5.4). However in the Pitx3 null striatum there 
was a lack of TH antibody staining in the dorsal caudate putamen, which is the target 
innervation area for SNc neurons.  Yet in the VTA target areas, which include the 
ventral caudate putamen, nucleus accumbens and olfactory tubercle, TH staining 
was present in Pitx3 null mice. This confirms that the VTA neurons and their striatal 
projections remain intact and innervate the correct targets, whereas the SNc neurons 
and their afferents are lost or do not contain TH in Pitx3 null mice.     
5.3. Summary 
These studies have demonstrated that there is a progressive loss of mDA neurons in 
Pitx3 null mice which is restricted to the SNc. At E12.5 there is a 50% loss of Pitx3-
GFP+TH+ cells, however, at this stage it was not possible to determine if these were 
SNc or VTA cells. By E14.5 there is around a 60% loss of Pitx3-GFP+TH+ cells in the 
SNc of Pitx3 null mice. Eventually, by adulthood there is a complete loss of Pitx3-
GFP+TH+ neurons in the SNc of Pitx3 null mice. The fact that there are no TH or 
Pitx3-GFP expressing cells in the adult SNc indicates that the cells are actually lost 
rather than just down-regulated TH expression. However, there is also the possibility 
that the cells remain but have down-regulated both TH and Pitx3 expression and 
further evidence that these cells are actually lost via apoptosis is provided in chapter 
6. In addition to the loss of Pitx3-GFP+TH+ cells, during embryonic development there 
was a specific loss of TH expression in some Pitx3-GFP cells in Pitx3 null mice 
resulting in an increased number of Pitx3-GFP+TH- cells. At E12.5 there was a 
significant decrease in the number of Pitx3-GFP positive cells expressing TH in the 
Pitx3 null mice as compared to Pitx3 heterozygous. Furthermore, there was a loss of 
TH expression in Pitx3-GFP cells at E14.5 in Pitx3 null mice and by this stage it was 
clear that this loss of TH expression was restricted to the SNc. These data 
demonstrate that Pitx3 is not only required for the survival of mDA neurons but it is 
also involved in the regulation of TH expression in a subset of mDA neurons.   
 
Figure 5.1. Analysis of Pitx3 and TH expression in the E12.5 midbrain of Pitx3 
null mice.  
E12.5 Pitx3 heterozygous and Pitx3 null 20µm coronal midbrain sections stained with 
antibodies against GFP and TH. There are a reduced number of TH labelled cells in 
the Pitx3 null (A-C) as compared to the Pitx3 heterozygous (D-F). Scale bar 100µm.
 
Figure 5.2. Analysis of Pitx3 and TH expression in the E14.5 midbrain of Pitx3 
null mice.  
GFP and TH antibody stained E14.5 20µm coronal sections show that the loss of TH+ 
cells is restricted to the SNc in the Pitx3 null (D-F) as compared to the Pitx3 
heterozygous (A-C). Higher magnification images of the SNc of Pitx3 heterozygous 
(G-I) and Pitx3 null (J-L). Scale bar 200µm for A-F and 50 µm for G-L. 
 
Figure 5.3. Pitx3 regulates TH expression specifically in the SNc mDA neurons.  
Quantitative analyses showing the percentage of GFP-expressing cells that also 
express TH. E12.5 and E14.5 total results were obtained from the counting of all 
labelled cells in serial sections for three embryos from each genotype. E14.5 SNc 
and VTA results were obtained from five sample midbrain sections from three 
embryos from each genotype. 
 
Figure 5.4. Analysis of TH expression in the adult midbrain of Pitx3 null mice. 
Immunostaining for TH in coronal sections of wild type, Pitx3 heterozygous and Pitx3 
null adult mice brains reveals that the wild type and Pitx3 heterozygous midbrains are 
comparable and display TH expression in SNc and VTA neurons (A and B). Also, the 
striatal areas of wild type and Pitx3 heterozygous mice have TH-immunostaining 
throughout the caudate putamen (CP), nucleus accumbens (NA) and olfactory 
tubercle (OT) (D and E). However, the Pitx3 null mice have a complete loss of TH 
expressing cells in the SNc while the TH expression in the VTA remains intact (C). 
Accordingly the target area of the SNc the dorsal caudate putamen lacks TH 
immunostaining, while TH-immunostaining in the VTA target areas the ventral 








Figure 5.5. Analysis of Pitx3 and TH expression in the adult midbrain of Pitx3 
null mice. 
Coronal midbrain sections double immunolabelled with antibodies against GFP and 
TH show that there is a loss of both Pitx3-GFP and TH expressing cells in the SNc of 
Pitx3 null mice (C, D) as compared to Pitx3 heterozygous mice (A, B), whereas Pitx3-
GFP and TH expressing cells remain in the VTA of Pitx3 null mice (C, D). Scale bar 
300µm.
                    
Chapter 6  
Mechanism of cell loss in midbrain dopaminergic 
neurons of Pitx3 null mice  
6.1. Introduction 
In the SNc of Pitx3 null mice there is a deficit of Pitx3-GFP+ and TH+ cells (Chapter 
5). The loss of Pitx3-GFP+ and TH+ cells appears to be gradual throughout 
development with a reduction in the number of SNc Pitx3-GFP+TH+ cells by 
approximately 50% at E12.5 and 60% at E14.5 to a complete loss by adulthood. 
From the results obtained in chapter 5, it was not possible to ascertain whether the 
Pitx3-GFP+ and TH+ cells in the SNc of Pitx3 null mice were dying or not. Potentially 
these cells may still be present but have simply down-regulated expression of Pitx3 
and TH. Another possibility is that they may have down-regulated expression of Pitx3 
and TH and changed fate to become another neuronal subtype. To elucidate this 
situation a quantitative and qualitative assessment of cell death in the SNc was 
undertaken. To assess the likelihood of a cell fate change in the Pitx3 null SNc mDA 
neurons, further marker analysis was performed on these cells. In addition, a chimera 
study was carried out to identify whether the fate of the Pitx3 null SNc mDA cells 
could be rescued by any extracellular factors.   
6.2. Results 
6.2.1. SNc mDA cells are lost via apoptosis in Pitx3 null midbrain 
To investigate whether there is evidence of increased apoptosis in vivo and to allow 
the region where apoptosis occurs to be identified, sections from E14.5 and newborn 
mice were examined for evidence of cell death via apoptosis.  
6.2.1.1. TUNEL labelling in E14.5 midbrain sections 
Terminal deoxynucleotidyl transferase (TdT) dUTP nick end labelling (TUNEL) allows 
the marking of cells that are undergoing apoptotic cell death. The TUNEL process 
labels the free 3’-OH ends created by internucleosomal DNA fragmentation, which 
occurs during apoptosis, with digoxygenin labelled nucleotides which can then be 
detected with antibodies. TUNEL was performed on E14.5 midbrain sections along 
with GFP antibody staining. Quantitative analysis revealed that there was an 
increase in apoptotic cells in the Pitx3-GFP cells of Pitx3 null embryos as compared 
to Pitx3 heterozygous and this was restricted to the SNc (Fig. 6.1). The number of 
apoptotic cells is around 1% of Pitx3-GFP+ cells in the SNc (1.2 ± 0.3%) and VTA 
(1.1 ± 0.4%) of Pitx3 heterozygous and the VTA (1.2 ± 0.2%) of Pitx3 null although it 
increases by around 1% to 2.4 ± 0.3% in the SNc of Pitx3 null embryos (Fig. 6.1). An 
increase of 1% may seem negligible, however, as the TUNEL technique labels the 
execution phase of apoptosis, which in cell culture takes less than 6 hours, a small 
percentage of TUNEL positive cells can result in a great increase in cell death. For 
example, a degree of tissue degeneration of 25% per day can result from an 
apparent apoptosis of 2-3% of cells at any instant (Bursch et al., 1990).  
6.2.1.2. Nissl staining on newborn brain sections 
If cell death, rather than just the loss of dopaminergic cell phenotype, has occurred in 
the SNc of Pitx3 null mice then a decreased cellularity in the Pitx3 null SNc would be 
expected. Midbrain sections from newborn brains were Nissl stained to reveal the 
neuronal density and morphology in Pitx3 heterozygous and Pitx3 null mice.  This 
showed that there were much fewer neurons and decreased cellularity in the SNc of 
Pitx3 null midbrain compared to Pitx3 heterozygotes (Fig. 6.2). Furthermore, many of 
the cells remaining in the SNc of Pitx3 null mice were dead and displayed highly 
condensed pyknotic nuclei, a characteristic feature of apoptosis.  
6.2.2. Increased apoptosis of E14.5 Pitx3 null cells in primary culture 
The TUNEL assay revealed that in E14.5 Pitx3 null midbrain SNc cells were dying 
due to apoptosis. To investigate whether Pitx3 null cells can be rescued or continue 
to die via apoptosis when isolated from the midbrain environment they were cultured 
in an environment favouring DA neuron production. It has been reported that co-
culture of ES cells with PA6 cells results in efficient neuronal differentiation with a 
high proportion of TH-expressing neurons (Kawasaki et al., 2000).  Thus, primary 
mDA neurons were cultured on a layer of PA6 cells to support DA neuron 
differentiation and survival.  
Midbrains from Pitx3 heterozygous and Pitx3 null E14.5 embryos were dissected 
using the Pitx3-GFP marker as a guide to isolate the mDA cells in the ventral 
midbrain. Midbrain tissue was dissociated manually to a single cell suspension and 
cultured on a layer of PA6 cells for 24 hours before staining for antibodies against the 
activated form of caspase-3 and GFP (Ch. 2.3.1).  Caspase-3 is a major effector of 
neuronal apoptosis and can be induced by a variety of stimuli. This cell death 
protease undergoes cleavage to become activated before it catalyses the specific 
cleavage of many key cellular proteins. Quantitative analysis revealed a significant 
increase in the number of activated caspase-3 positive cells in the Pitx3-GFP cell 
population in the Pitx3 null cultures (6.0 ± 2.6%) as compared to the Pitx3 
heterozygous cultures (3.2 ± 1.7%) (Fig. 6.3).  
The rate of apoptotic cell death in the Pitx3 null mDA cells is around two-fold higher 
than in Pitx3 heterozygous mDA cells in this PA6 co-culture system, which is a 
similar fold increase to that observed by TUNEL labelling in midbrain sections (Ch 
6.2.1.1). This suggests that the factors provided by the PA6 cells and culture media 
cannot rescue the fate of the Pitx3 null mDA cells.  
6.2.3. Is there a cell fate change for Pitx3 null mDA cells? 
The progressive restriction of neural cell fate involves the interplay of both extrinsic 
and intrinsic signals and may occur at many different stages and times during 
development (Edlund and Jessell, 1999). Transplantation experiments may be used 
to assess the degree of cell fate commitment to certain neuronal subtypes at different 
stages of development. Transplanting En1 expressing midbrain cells to the forebrain 
revealed that at E10.5 the majority of these cells can be respecified to a forebrain 
phenotype, however at E13.5 the majority of transplanted cells do not integrate and 
still express midbrain markers (Olsson et al., 1997). As En1 is expressed in mDA 
progenitors at E10.5 and mDA neurons at E13.5, these studies suggest that mDA 
progenitors become restricted in their potential between E10.5 and E13.5.  
The experiments above show that at least some of the Pitx3 null SNc mDA cells are 
lost due to apoptotic cell death. To investigate the possibility that some Pitx3 null 
cells may undergo a fate change, the expression of the mDA marker En1 and the 
GABAergic neuron marker GAD were assessed in E12.5 and E14.5 Pitx3 null 
midbrains. Analysis of GABAergic neurons was selected because the SNc and VTA 
of adult mice contains GABAergic neurons as well as mDA neurons [Sarabi, 2001 
#151;Michel, 2004 #150], however, little is known about the developmental 
expression of GAD in the midbrain. At E12.5 and E14.5, Pitx3-GFP cells in the Pitx3 
null midbrain expressed En1 (Fig. 6.4, G-L), which suggests that these cells are mDA 
phenotype rather than any other neuron type. In concurrence, the anti-GAD antibody 
labelled cells dorsal to the mDA neuron domain which was distinct from the Pitx3-
GFP expressing domain (Fig. 6.4, A-F), indicating that all Pitx3 expressing cells at 
E12.5 and E14.5 are not GABAergic neurons. However, the possibility that Pitx3 null 
cells may change fate accompanied with a downregulation of Pitx3-GFP expression 
cannot be ruled out.  
6.2.4. Pitx3 acts in a cell autonomous manner 
To investigate whether Pitx3 or any of its downstream targets were able to act in a 
cell non-autonomous manner and rescue Pitx3 null cells in the SNc, a chimera study 
was performed. Chimeric embryos were generated from either Pitx3 heterozygous or 
Pitx3 null ES cells with wild type host embryos using the diploid aggregation method 
(Ch. 2.4.5) (all aggregations and embryo transfers were performed by R. MacLay, G. 
Russell, and J. Agnew at the ISCR).  The chimeras produced displayed varying 
degrees of chimerism and some had such a great extent of contribution from the 
Pitx3-GFP cells that they resembled the non-chimeric Pitx3 heterozygous or Pitx3 
null midbrain phenotype.  In this situation there is not likely to be a competition effect 
between wild type and Pitx3-GFP cells, so lower level chimeras (approximately 30-
70% Pitx3-GFP cell contribution) were used for analysis. Sections from the midbrains 
of E14.5 chimeric mice were analysed using antibodies against GFP to detect the 
Pitx3 heterozygous or Pitx3 null cells and TH to reveal all the mDA neurons and 
therefore reveal the SNc and VTA structures. In chimeric mice made with Pitx3 
heterozygous ES cells the Pitx3-GFP cells contributed to both the VTA and the SNc 
areas (Fig 6.6). On the other hand, in chimeric mice made with Pitx3 null ES cells the 
Pitx3-GFP cells showed contribution to the VTA but rarely to the SNc (Fig 6.6). As 
the level of chimerism in each embryonic chimeric mouse was different, the 
quantitative analysis could not be based on absolute numbers. Instead, the ratio of 
the number of Pitx3-GFP cells in the SNc to the number of Pitx3-GFP cells in the 
VTA was compared between chimeras. The VTA acts as a control region where no 
variation is expected between the Pitx3 heterozygous and the Pitx3 null ES cell 
contribution as the VTA phenotype is not significantly different in Pitx3 heterozygous 
and Pitx3 null E14.5 embryos (Ch. 5.2). This demonstrated quantitatively that the 
Pitx3 null cells were impaired in contributing to the SNc, as the ratio of SNc:VTA 
Pitx3-GFP cells in the chimeras made with Pitx3 null ES cells (0.017 ± 0.01) was 
much lower than in the chimeras made with Pitx3 heterozygous ES cells (0.22 ± 
0.05) (Fig. 6.6).  The interpretation of this experiment is limited, however, by the fact 
that the donor Pitx3-GFP ES cells can only be detected by virtue of their Pitx3-GFP 
expression. As there is no constitutive marker for the donor ES cell-derived cells in 
this system, Pitx3-GFP cells which have contributed to the SNc but have 
downregulated Pitx3-GFP expression are therefore undetectable.  
As an additional control, the SNc:VTA Pitx3-GFP cell number ratios in non-chimeric  
Pitx3 heterozygous and Pitx3 null mice were analysed. If the ES cells used to make 
chimeras are not impaired in their ability to contribute to the SNc, it would be 
expected that the SNc:VTA Pitx3-GFP cell ratio in the chimeric mice would be the 
same as the ratio observed in non-chimeric mice. As shown above the Pitx3 null cells 
are impaired in their ability to contribute to the SNc and as expected the ratio of 
SNc:VTA Pitx3-GFP cells in the Pitx3 null chimeric mice (0.017 ± 0.01) is much lower 
than the ratio in the Pitx3 null mice (1.05 ± 0.22).  However, the SNc:VTA Pitx3-GFP 
cell ratio in the chimeric mice made with Pitx3 heterozygous ES cells (0.22 ± 0.05) is 
also much lower than the in Pitx3 heterozygous mice (1.38 ± 0.25) (Fig. 6.6). This 
suggests that the Pitx3 heterozygous ES cells also have a reduced ability to 
contribute to the SNc, but this defect is only apparent when these cells are 
challenged such as in the chimera situation.    
6.3. Summary 
These studies imply that in Pitx3 null mice SNc mDA neurons are lost due to 
apoptosis rather than down-regulation of TH and Pitx3 expression or a change of fate 
into another cell-type. The TUNEL assay and Nissl staining performed on Pitx3 null 
embryonic and neonate midbrains, respectively, have provided evidence of apoptotic 
cell death restricted to the SNc in Pitx3 null mice. Further support was given by 
primary culture studies of embryonic midbrain cells which revealed that there was a 
two-fold increase in apoptotic cell death in Pitx3 null mDA cells as compared to Pitx3 
heterozygous mDA cells. It is difficult to fully assess whether there is a change of cell 
fate of Pitx3-GFP cells in Pitx3 null mice, however, it seems unlikely as embryonic 
Pitx3-GFP cells in Pitx3 null mice express the dopaminergic neuron marker En1 and 
do not express GABAergic neuron markers. Additionally, the effect of Pitx3 
expression in mDA cells is cell autonomous as chimera studies revealed that wild 
type mDA cells were unable to rescue the Pitx3 null SNc cells. 
 
Figure 6.1. TUNEL analysis of E14.5 Pitx3 heterozygous and Pitx3 null 
midbrains. 
The bar chart shows the percentage of Pitx3-GFP expressing cells that were TUNEL 
labelled. Midbrain sections from 3 mice were analysed for each genotype. There 
were significantly more Pitx3-GFP+ TUNEL labelled cells in the SNc of Pitx3  null 
(2.34 ± 0.33%) as compared to Pitx3 heterozygous (1.18 ± 0.31%),  P= 0.01 
(student’s t-test). Whereas the VTA of the Pitx3 null (1.16 ± 0.23%) and Pitx3 
heterozygous (1.11 ± 0.46%) were similar, P= 0.85 (student’s t-test). 
 
Figure 6.2. Nissl staining on newborn Pitx3 heterozygous and Pitx3 null 
midbrain sections. 
Nissl staining was performed on newborn brain sections from Pitx3 heterozygous (A 
and B) and Pitx3 null (C and D) mice.  Parallel sections stained with TH antibodies 
were used to orientate the region of the SNc in the Nissl stained sections. Scale bars 
200µm. 
 
Figure 6.3. Activated caspase-3 expression is increased in Pitx3 null E14.5 
midbrain primary cultures. 
The bar graph shows the percentage of Pitx3-GFP cells that also expressed 
activated caspase 3 in primary cultures of Pitx3 heterozygous (3.2 ± 1.7%) and Pitx3 
null (6.0 ± 2.6%) midbrain cells.  For each genotype 15 wells from a total of 3 
separate experiments were analysed and on average there were around 150 Pitx3-
GFP positive cells per well. 
 
Figure 6.4. Marker analysis in Pitx3 null midbrains 
Coronal sections from E12.5 and E14.5 Pitx3 null midbrains were stained with 
antibodies against GAD (red) and GFP (green) (A-F) or En1 (red) and GFP (green) 
(G-L). The Pitx3-GFP cells do not express GAD (A-F) but do express En1 (G-L) at 
E12.5 and E14.5. Scale bars 100µm for A-C and G-I, 200µm for D-F and J-L. 
 
Figure 6.5. Chimeras made with Pitx3 heterozygous or Pitx3 null ES cells and 
wild type embryos 
Chimeric E14.5 embryos made with Pitx3 heterozygous ES cells (A-C) and Pitx3 null 
ES cells (D-F) were cryosectioned at 30µm and stained with antibodies against TH 
and GFP. The mDA neurons in the embryo will be stained with TH and only the cells 
from either the Pitx3 heterozygous or null ES cells will be GFP-positive. The Pitx3 
heterozygous cells contributed to both the VTA and SNc (A-C) whereas the Pitx3 null 
cells contributed to VTA but not the SNc (D-F). Scale bar 200µm.
 
Figure 6.6. Analysis of chimeras made with Pitx3 heterozygous or Pitx3 null ES 
cells and wild type embryos 
The chimeric embryo midbrains were analysed by counting all of the Pitx3-GFP 
expressing cells in the SNc and VTA using Volocity software (Improvision). To 
normalise for differences in the overall level of chimerism, the VTA was used as a 
control area and the ratio of GFP cells in the SNc:GFP cells in the VTA was 
calculated. As an additional control, the ratios of GFP cells in the SNc:GFP cells in 
the VTA from Pitx3 heterozygous and Pitx3 null mice were calculated from previous 
quantitative data (Ch. 5.2). Three chimeric embryos were analysed for each 
genotype.            
Chapter 7  
Production of Pitx3-CreERT2 ES cells and mice  
7.1. Introduction 
The data revealed in this study has led to the hypothesis that the differential 
regulation of Pitx3 expression early in mDA development may determine whether 
mDA neurons will contribute to the SNc or VTA. Two main lines of evidence have 
contributed to this hypothesis, firstly, the analysis of Pitx3 heterozygous mice led to 
the identification of two subgroups of mDA neurons at an early stage of mDA neuron 
generation (E12.5). These two subgroups are identified by their differential temporal 
and topographical expression patterns of Pitx3 and TH. At E12.5 there is a subgroup 
present in a more ventral and lateral position that expresses Pitx3 but not TH and a 
subgroup present in a more dorsal and medial position that expresses TH but not 
Pitx3 (Ch. 4.2). Secondly, even though Pitx3 is expressed in both the SNc and VTA, 
the loss of Pitx3 results in the loss of TH expression in mDA neurons of the SNc and 
a loss of SNc mDA neurons via apoptosis (Ch’s. 5 and 6), whereas the VTA remains 
relatively unaffected. As Pitx3 has different functions in the SNc and the VTA it is 
likely that its expression with respect to TH expression is regulated differentially in 
the SNc and VTA.  
At E12.5 the architecture in the midbrain does not correlate with the organisation of 
the mDA neurons in the adult, hence it is not possible to ascertain which neurons will 
form the SNc and which will form the VTA from their anatomy. Additionally, no 
markers are known that reliably distinguish between SNc and VTA cells at this stage 
of development. However, the position of the ontogentically distinct mDA subgroups 
at E12.5 is indicative that the more lateral Pitx3+TH- group will migrate most laterally 
to form the SNc, whereas the Pitx3-TH+ group are in a more medial start position so 
they will form the VTA (Ch. 4.2). The route by which mDA neuron progenitors migrate 
from the ventricular zone and come to their final destination is controversial. The so 
called ‘inverted fountain’ model proposes that mDA precursors are generated in the 
medial part of the neuroepithelium and migrate ventrally down the midline before 
migrating laterally to their final position (Hanaway et al., 1971; Kawano et al., 1995; 
Marchand and Poirier, 1983). On the other hand, it has been proposed that mDA 
precursors generated from the medial ventral one-third of the ventricular zone and 
migrate radially, perpendicular to the ventricle (Smidt et al., 2004) (see Ch 8.5 and 
Fig. 8.1).  The orientation of the TH+ neurons in the midbrain at E12.5 in this study 
supports this ‘inverted fountain’ model of mDA neurogenesis. Analysis of mDA cell 
bipolar orientation at E12.5 revealed that the TH+ cells located closer to the medial 
part of the neuroepithelium exhibited an orientation suggestive of a vertical migration 
route, whereas TH+ cells located in a lateral position had an orientation suggestive of 
a horizontal migration route (Ch 4.2.3). Taking these data together it seems probable 
that the two ontogenetically distinct subpopulations observed at E12.5 correspond 
with SNc and VTA forming cell populations and that the mDA cells that express Pitx3 
before TH will form the SNc, while the mDA cells that express TH before Pitx3 will 
form the VTA. Therefore, to test this hypothesis, cell fate tracking experiments are 
required to track the fate of cells from the E12.5 Pitx3+TH- population to their final 
destination.   
7.2. Cell fate tracking strategy 
A number of methods both genetic and non-genetic can be used for tracking cell 
lineage. The non-genetic approaches involve labelling cells based on their location 
with a marker such as a dye or a replication incompetent retrovirus. The vital 
carbocyanine dyes, such as DiI and DiO, are lipid-soluble and water-insoluble so 
they partition to the cell membrane and do not transfer between cells. In order to 
track cell fate these dyes can be injected into the tissue of interest, however it is 
difficult to apply them to a single cell and they are usually used to label groups of 
cells (Stern and Fraser, 2001). For example, DiI has been injected into the 
developing mouse hindbrain in combination with in vitro whole embryo culture to map 
the patterns of cranial neural crest cell migration into the developing branchial arches 
(Trainor et al., 2002). As the Pitx3- and TH-expressing cell populations are in such 
close proximity to each other at E12.5 it would be technically unachievable to label 
either population exclusively using this method. Furthermore, it is not feasible to 
culture an embryo of this age for the required amount of time. Another way to non-
genetically label cells is to introduce a replication incompetent retroviral vector 
encoding a reporter gene. The replication incompetent retroviral vector is able to 
infect cells and transduce a non-viral gene, it is passed on to all daughter cells but it 
does not infect neighbouring cells (Cepko et al., 1998). Such a low concentration of 
the virus can be given that single cells are labelled, however infection is random and 
cells cannot be selected. In addition only mitotic cells can serve as successful hosts 
for retroviruses (Cepko et al., 1998). Thus, as well as being unable to label specific 
cells this method is also unsuitable to label Pitx3-expressing cells as they are post-
mitotic (Ch. 4.2.2).  
To label and track the progeny of single cells a mutated form of the reporter gene 
lacZ called laacZ has been developed. LaacZ has an internal duplication that results 
in the premature termination of translation and so does not produce lacZ enzyme. 
However, a rare (<1 in 10000) intragenic homologous recombination event 
regenerates the functional lacZ gene (Bonnerot and Nicolas, 1993). This technology 
can be used for retrospective clonal analysis in a specific cell or tissue type by 
placing the laacZ gene under the control of a specific promoter. This results in the 
random labelling of relatively few cells and all of their progeny during development 
(Mathis et al., 1997). Although, again this method is not suitable to track the fate of 
the SNc or VTA cells as it is a tool for clonal analysis and the Pitx3-expressing 
midbrain cells are post-mitotic.  
Another approach is to take advantage of endogenous gene expression patterns to 
label specific cell lineages. The simplest transgenic method involves placing the 
expression of a reporter gene under the control of the gene of interest, as in the case 
of the Pitx3-GFP mice. However, this approach is unsuitable to test the lineage of 
SNc and VTA as they both express Pitx3 and there are no well characterised genes 
that are expressed exclusively in either cell population during development. The 
Cre/loxP system can also be used to label cells expressing a gene of interest. Two 
transgenic mouse lines are required, one containing a reporter gene that is disrupted 
by a loxP flanked sequence and under the control of a ubiquitous promoter and 
another that expresses Cre recombinase under the control of the promoter of the 
gene of interest. Thus the reporter gene is only expressed in cells in which Cre is 
active and so able to excise the loxP flanked disruptive sequence and allow reporter 
gene expression (Zinyk et al., 1998). The main advantage of this over the simple 
transgene expression is that cells are irreversibly marked by the expression of Cre, 
so progeny of the cells that no longer express the gene of interest will still express 
the reporter gene.    
An enhancement of the Cre/LoxP system that includes temporal control uses the 
tamoxifen-inducible form of Cre recombinase, CreERT2, in which Cre recombinase 
has been fused to a mutated version of the estrogen receptor (ER) ligand binding 
domain. CreERT2 is activated by the artificial ligand tamoxifen but not by estradiol 
that may be present endogenously in mice (Feil et al., 1996; Feil et al., 1997). This 
system is ideal to track the migration and final destination of the earliest Pitx3-
expressing midbrain cells as it allows control of the reporter allele spatially by 
restricting it to Pitx3-expressing cells and temporally by administering tamoxifen to 
activate Cre and consequently the reporter expression.   
The feasibility of this approach is supported by recent studies that have employed a 
similar strategy to fate map other neuronal lineages during embryonic development.  
For example, the pattern of cell migration in the cerebellum and midbrain-hindbrain 
regions have been analysed using En1 and En2-CreERT2 (Sgaier et al., 2005) and 
Wnt1, En1 and Gli1-CreERT2 (Zervas et al., 2004) mouse lines, respectively. 
Tamoxifen was administered at various stages between E8.5 and E11.5 and this 
resulted in labelling of cells expressing CreERT2 24 to 36 hours after tamoxifen 
administration via oral gavage (Sgaier et al., 2005; Zervas et al., 2004). Furthermore, 
it has been noted that nuclear translocation of CreER occurs within 6 hours, is 
sustained for approximately 24 hours and no further recombination events take place 
48 hours after tamoxifen administration (Hayashi and McMahon, 2002; Zervas et al., 
2004). Therefore, to track the fate of the E12.5 Pitx3+TH- cells it is estimated that 
tamoxifen would be given at around E10.5 in order that Cre will only be active until 
E12.5 (Fig. 7.1). Although, the timing and dose of tamoxifen will need to be optimised 
for this particular experiment to ensure that only cells expressing Pitx3 at E12.5 are 
labelled.  
In addition to the use of the Pitx3-CreERT2 mice for tracking the fate of the early 
Pitx3-expressing cells, they should be a useful tool for the inactivation of specific 
genes in mDA neurons in a temporally controlled manner. A number of mouse lines 
containing floxed genes have already been created and a database of these lines is 
available (http://www.mshri.on.ca/nagy/floxed.html). Pitx3-CreERT2 mice will be 
particularly useful for investigating the specific mDA role of genes that are more 
broadly expressed or have lethal knock-out phenotypes. In addition the temporal 
regulation provided by tamoxifen administration could be employed to create a more 
accurate animal model of Parkinson’s disease by disrupting certain genes at later 
stages of adulthood (Ch. 8.7).   
7.3. Results 
 
7.3.1. Construction of Pitx3-CreERT2 targeting vector 
In order to have the CreERT2 under the control of the endogenous Pitx3 promoter a 
promoterless En2SA-CreERT2 cassette and a pCMVHygroTK selection cassette were 
used. The Engrailed 2 splice acceptor (En2SA) allows the cassette to be inserted into 
an intron with efficient mRNA processing (Gossler et al., 1989). The HygroTK is a 
result of fusing the hygromycin phosphotransferase (Hygro) gene with the herpes 
simplex virus type-1 thymidine kinase (TK) gene, which confers hygromycin B 
resistance for positive selection and ganciclovir sensitivity for negative selection 
(Lupton et al., 1991). Additionally, the HygroTK was flanked by loxP sites (floxed) so 
that it could be used to screen for homologous recombinant ES cell clones and then 
later removed using Cre recombinase. An existing vector (Pitx3KO3, created by S. 
Zhao) containing a pCMVHygroTK gene flanked by a 1.9kb Pitx3 5’ homologous arm 
and a 5.8kb Pitx3 3’ homologous arm was used as the basis for the CreERT2 
targeting vector. The HygroTK is under the control of the cytomegalovirus immediate 
early-enhancer (pCMV) which gives high levels of transgene expression in ES cells 
(Ward and Stern, 2002). In order to get the En2SA and CreERT2 fragments in 
sequence together and flanked by suitable restriction sites, a 2.1kb NotI-KpnI 
CreERT2 fragment from a pBluescript vector containing CreERT2 (pBSCreERT2, a gift 
from L. Grotewold) and a 1.9kb XhoI-NotI En2SA fragment were three-way cloned 
into a XhoI-KpnI cut pSP72poly4 vector to create pSP72poly4En2SA-CreERT2. The 
pSP72poly4En2SA-CreERT2 vector was cut with SalI to release the 3.9kb En2SA-
CreERT2 fragment which was inserted into the XhoI sites of Pitx3KO3 in between the 
Pitx3 5’ homologous arm and the floxed pCMVHygroTK, to create Pitx3-CreERT2 
plasmid (Fig. 7.2). This strategy is similar to the Pitx3-GFP targeting strategy and 
results in the replacement of the entire Pitx3 coding sequence. As the mice used in 
the fate mapping study will be heterozygous for the mutated Pitx3 allele, the 
development and survival of mDA neurons will not be affected.   
7.3.2. Electroporation and screening for homologous recombinant ES 
cells 
The targeting vector was electroporated into E14TG2a ES cells as described in 
materials and methods (Ch. 2.5). Following electroporation the selection of ES cell 
transfectants was achieved by adding hygromycin B to the media. 583 hygromycin B 
resistant clones were picked and expanded in 24-well plates before splitting to freeze 
half and use half for genomic DNA preparation. In order to screen for homologous 
recombinant ES cell clones, genomic DNA from all of the hygromycin-resistant 
clones was digested with HindIII enzyme and Southern blotted. The probe used for 
Southern blotting was a 3kb fragment corresponding to the endogenous Pitx3 5’ 
region immediately upstream of the targeted Pitx3 5’ homologous arm. This probe 
detects the 9.5kb fragment of the wild type allele and the 8.0kb fragment of the 
mutant allele (Fig 7.3). Three of the 583 ES cell clones screened displayed the 9.5kb 
fragment for the wild type allele plus the 8.0kb fragment for the recombinant allele. 
The rest of the clones displayed only the 9.5kb fragment for the wild type (Fig. 7.3).  
Thus the targeting efficiency for this experiment was 0.5%. The positive clones which 
had been frozen at -80°C were recovered and thawed (Ch. 2.4), however, only one 
of the three positive clones, clone 450, survived the freeze-thaw process. This clone 
was used for all further experiments.    
7.3.4. Excision of selection cassette 
Male transgenic mice carrying the TK gene rarely transmit the transgene and are 
usually infertile as a result of ectopic reporter expression in the testis (Al-Shawi et al., 
1988; al-Shawi et al., 1991; Braun et al., 1990; Ellison et al., 2000). Therefore, to 
allow transmission of the CreERT2 transgene the pCMVHygroTK selection cassette 
was removed from the targeted clone 450 line of ES cells. Cre recombinase was 
transiently expressed in 450 ES cells using the plasmid pCAGCre in which Cre is 
under the transcriptional control of the CAG promoter (which possess the CMV 
immediate early enhancer and chicken -actin promoter). Ganciclovir was used to 
select for ES cells lacking the TK gene and 12 ganciclovir resistant clones were 
picked (Ch 2.5).   
7.3.5. Chimera production and germline transmission  
Four of the pCMVHygroTK-deleted subclones were selected to make chimeras for 
germline transmission of the Pitx3-CreERT2 allele (Table 7.1). Chimeras were made 
using the diploid aggregation method (Ch.2.4.5) performed by G. Russel, K. Jones, J. 
Ure and J. Agnew. Chimeric pups were identified by coat colour chimerism. The 
E14TG2a ES cells are from Ola/129 mice which carry the agouti gene at the Aw 
locus and chinchilla at the C locus resulting in light buff coat colour and the host 
embryos were C57Bl/6 X CBA F1 mice which are agouti (brown coat colour). Of a 
total of 191 blastocysts implanted and 26 pups born, 4 of these were chimeric. The 
four male chimeric mice were mated with C57Bl/6 (black coat) female mice and one 
of the clone 450-8 chimeric mice was germline transmitting and produced Pitx3-
CreERT2 heterozygous offspring (Fig.7.4).   
Table 7.1. Summary of chimera production and germline transmission 
ES cell clone Blastocysts 
implanted 




450-1 58 2 1 (1) - 
450-2 53 7 1 (1) - 
450-6 38 4 0 - 
450-8 42 13 2 (2) 1 
  
7.4. Summary 
Mice containing CreERT2 under the control of the endogenous Pitx3 promoter were 
created in order to perform a cell fate tracking study to test the hypothesis that the 
mDA cells that express Pitx3 before TH will form the SNc. A targeting construct was 
made using an En2 splice acceptor-CreERT2 cassette inserted in between 5’ and 3’ 
Pitx3 homologous arms. This targeting vector was electroporated into ES cells and 
incorporation of the CreERT2 cassette into the ES cell DNA via homologous 
recombination occurred at a rate of 0.5%. One of the CreERT2 containing clones was 
used to create germline transmitting chimeric mice.   
 
Figure 7.1. Diagram of cell fate tracking strategy 
Tamoxifen will be administered to mother at E10-E11 (exact time will have to be 
determined empirically) in order to label only Pitx3-expressing cells at E12.5 and no 
later. Cre will be translocated to the nucleus in the Pitx3-CreERT2 expressing cells at 
E12.5 and will act to recombine the loxP sites which will remove the “stop” codon 
therefore activating the GFP expression. These cells labelled at E12.5 will remain 
GFP-labelled throughout development. Brains can then be collected at later stages of 
embryonic development or post-natal and the location of the GFP-labelled cells can 
be analysed. 
                       
Figure 7.2. Targeting vector construction 
A 1.9kb XhoI-NotI En2SA fragment and a 2.1kb NotI-KpnI CreERT2 fragment from 
pBSCreERT2 were three-way cloned into a pSP72poly4 vector cut with XhoI-KpnI to 
create pSP72poly4En2SA-CreERT2. Subsequently, the pSP72poly4En2SA-CreERT2 
plasmid was cut with SalI to release the 3.9kb En2SA-CreERT2 fragment which was 
ligated into the Pitx3KO3 that had been cut with XhoI, inserting En2SA-CreERT2 in 
between the Pitx3 5’ homologous arm and the floxed pCMVHygroTK to create the 
Pitx3-CreERT2 plasmid. See appendix for plasmid maps. 
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Figure 7.3. Southern blotting screening strategy for correctly targeted clones 
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(A) From the top is the Pitx3-CreERT2 targeting construct, the wild type Pitx3 locus 
and the targeted Pitx3 locus. The boxes on the Pitx3 locus represent the Pitx3 exons 
1 to 4, blank boxes are non-coding and filled boxes are coding sequence. 
Homologous recombination at the Pitx3 5’ and 3’ homologous arms results in the 
replacement of the entire coding sequence of Pitx3 with the En2SACreERT2-HygroTK 
cassette. Selection of clones in which homologous recombination had occurred was 
achieved by Southern blotting genomic DNA digested with HindIII. The location of the 
3kb 5’ probe is indicated by a green oval, thus it detects the 9.5kb fragment of the 
wild type allele and the 8.0kb fragment of the mutant allele. 
(B) Southern blot showing the three positive clones 21, 23 and 450, an example of 
wild type clone (wt) and positive control DNA (+) from the Pitx3-GFP ES cells (Ch. 
3.1). The wild type band is at 9.5kb, the Pitx3-CreERT2 band at 8.0kb and the Pitx3-
GFP band at 7.2 kb.  
 
Figure 7.4. Southern blotting for detection of germline transmission 
Southern blot showing genomic tail DNA from three pups (lanes 1 to 3) from a mating 
with chimeric mouse 450-8 (strategy as in Fig. 7.3). Two of the pups are 
heterozygous for the Pitx3-CreERT2 allele (8.0kb and 9.5kb band, lanes 2 and 3) and 
one is wild type (9.5kb band only, lane 1). Lane 4 shows positive control DNA from 
clone 450 ES cells (8.0kb and 9.5kb band) and lane 5 is negative control DNA from 
wt mouse tail (9.5kb band only).                     
Chapter 8  
Discussion  
The mDA neurons have a variety of key functions in the brain, the SNc mDA 
neurons in motor control and the VTA mDA neurons in mood and reward pathways. 
Degeneration of the SNc neurons results in PD, whereas the dysfunction and/or 
degeneration of VTA neurons is implicated in addiction and schizophrenia. 
Therefore, there is much interest in the study of mDA neuron physiology, 
development and pathogenesis. In order to understand more about the physiology 
and pathogenesis of these neurons and to advance the derivation of mDA neurons 
from ES cells, knowledge of the regulation of their development is required. So far, 
a small number of factors known to be involved in the development and survival of 
mDA neurons have been identified including Nurr1, Engrailed 1 and 2 and Lmx1b. 
However, the signalling cascades and interactions between the factors involved 
remain to be uncovered. In this thesis I have demonstrated the importance of one 
other factor, the homeodomain transcription factor Pitx3. Pitx3 is required for TH 
expression and cell survival specifically in SNc mDA neurons, although it is 
expressed in both the SNc and VTA mDA neuron populations. Furthermore, this 
study has shown that at around the start of mDA neuron generation there are two 
previously unrecognised ontogenetically distinct subsets of mDA neurons based on 
their expression of Pitx3 and TH. Currently there is little known about the differences 
between SNc and VTA mDA neuron development, however, these findings may 
provide the basis for diverse developmental pathways of the anatomically and 
functionally distinct SNc and VTA subpopulations.   
8.1. Pitx3-GFP is an accurate marker of Pitx3 expression 
Previously a Pitx3-GFP reporter mouse line was created to act as a reporter of Pitx3 
gene expression and to create a mutation in the Pitx3 gene which resulted in a Pitx3 
null allele. The first aim of this thesis was to validate the Pitx3-GFP reporter mouse 
line as a tool for studying Pitx3 expression. It was found that the expression of the 
Pitx3-GFP reporter in phenotypically normal Pitx3-heterozygous embryos mirrored 
that of Pitx3. Pitx3-GFP was detected in the midbrain, lens, somites, cranial facial 
muscles and the tongue, which correlates with those sites previously reported for 
Pitx3 mRNA expression (Semina et al., 2000; Semina et al., 1997; Smidt et al., 
1997). So far, the requirement for the function of Pitx3 in the eye and the midbrain 
has been established (Rieger et al., 2001; Semina et al., 2000), however, no data is 
available on any role of Pitx3 in the other sites of expression including the tongue, 
head mesenchyme and somites.  
In the midbrain, the first stage at which Pitx3-GFP and Pitx3 protein expression could 
be detected was at E12.5, yet Pitx3 mRNA expression has been reported to be first 
detected in the midbrain at E11.5 (Smidt et al., 1997). As this study was looking at 
protein rather than mRNA expression this delay may be due to the time it takes for 
Pitx3-GFP mRNA to be translated and folded into protein. Also, our technique may 
not be as sensitive as the radioactive in situ technique used to reveal Pitx3 mRNA 
expression at E11.5 (Smidt et al., 1997). Using an antibody against Pitx3 revealed 
that Pitx3-GFP expression exactly represented Pitx3 protein expression in the 
midbrain at E12.5. This demonstrates that Pitx3-GFP is a faithful marker of Pitx3 
protein expression.   
A recent study had reported that Pitx3 was expressed in only some cells of the adult 
SNc and VTA. It claimed that in the SNc Pitx3 was expressed in the ventral mDA 
neurons but not in the dorsal mDA neurons, and that throughout the VTA Pitx3 was 
only expressed in around half of the mDA neurons (Van Den Munckhof et al., 2003). 
In contrast, my work has demonstrated that in the adult midbrain Pitx3 is expressed 
in almost all TH-expressing cells in the SNc and VTA and vice versa (Ch. 3.2). 
Another recent study has also shown the co-expression of Pitx3 and TH in all adult 
mDA neurons (Smidt et al., 2004), which adds further support for Pitx3 as a marker 
for mDA neurons of the adult SNc and VTA.    
8.2. Pitx3 is required for the regulation of TH expression in SNc mDA 
neurons 
A role for Pitx3 in TH regulation has previously been suggested by in vitro promoter 
studies. These studies have shown that there is a response element for Pitx3 in the 
TH promoter which Pitx3 is able to bind to and confer a transcriptional effect in vitro 
(Cazorla et al., 2000; Lebel et al., 2001). This thesis however, provides the first in 
vivo evidence of a role for Pitx3 in TH regulation and reveals that this function of 
Pitx3 is restricted to a subset of mDA neurons. Firstly, based on the finding that there 
are around 50% fewer Pitx3-GFP+TH+ cells but no change in the number of Pitx3-
GFP+TH- cells at E12.5, this study demonstrates that Pitx3 is required for the 
expression of TH in some Pitx3-expressing cells and thus for the transition from post-
mitotic mDA progenitor cells (Pitx3-GFP+TH-) to mDA neurons (Pitx3-GFP+TH+) at 
E12.5. At E14.5 it was shown that the specific loss of TH expression was restricted to 
Pitx3-GFP+ cells of the SNc whereas the VTA cells mostly co-expressed Pitx3-GFP 
and TH. Therefore the crucial role of Pitx3 in regulation of TH expression is restricted 
to SNc cells and is not in VTA cells. The in vitro promoter studies on Pitx3 regulation 
of the TH promoter have shown that the magnitude of the transcriptional effect of 
Pitx3 on the TH promoter was cell type-dependent (Cazorla et al., 2000; Lebel et al., 
2001). Although none of the cell lines used in these studies were mDA neuron-
derived, the results imply that a similar cell type-dependent mechanism could take 
place between mDA neuron subtypes. Pitx3 may act on its own to activate the TH 
promoter or it may interact with other molecules to achieve this effect. One candidate 
Pitx3 interacting partner that is expressed in all mDA neurons is Nurr1, which 
functions as a general TH regulator as TH expression is lost in both the SNc and 
VTA of Nurr1 mutant mice (Saucedo-Cardenas et al., 1998; Zetterstrom et al., 1997). 
One study has found that Nurr1 can act co-operatively with Pitx3 to enhance the 
effect of Pitx3 on the TH promoter (Cazorla et al., 2000), however another study has 
refuted this claim reporting that Nurr1 does not enhance the ability of Pitx3 to activate 
the TH promoter (Lebel et al., 2001). These studies were performed using different 
cell systems, Neuro2A and P19 cells respectively, so this discrepancy between the 
studies may imply that the combined effects of Pitx3 and Nurr1 may be cell type-
dependent.  Furthermore, the activation of TH gene expression by Nurr1 has been 
reported in the context of cultures of adult rat hippocampal progenitor cells (Sakurada 
et al., 1999), SK-N-BE(2)C and HeLa cells (Kim et al., 2003). However, in a number 
of cell types it was shown that Nurr1 had little or no effect on TH expression 
suggesting that the transactivation of the TH promoter by Nurr1 is also cell type-
specific (Kim et al., 2003).   
8.3. Pitx3 is required for the survival of SNc mDA neurons 
This study has demonstrated that there is a progressive loss of SNc mDA neurons in 
Pitx3 null mice starting at an early stage of mDA generation to result in a complete 
absence of SNc mDA neurons in adult Pitx3 null mice. At E12.5, the first stage at 
which Pitx3 protein can be detected, there is a 50% loss of Pitx3-GFP+TH+ cells. By 
E14.5 there is around a 60% loss of Pitx3-GFP+TH+ cells in the SNc of Pitx3 null 
mice. Eventually, by adulthood there is a complete loss of mDA neurons in the SNc 
of Pitx3 null mice. This supports the concept that Pitx3 is dispensable for the 
specification of post-mitotic mDA progenitor neurons, rather it is required for the 
survival and maintenance of a population of post-mitotic mDA (i.e.TH+) neurons.  
An intriguing finding at E12.5 was the significant loss of Pitx3-GFP-TH+ cells in Pitx3 
null mice at E12.5. As these cells are not yet expressing Pitx3 it is surprising that 
they are affected in the Pitx3 null mice. One explanation for this could be that these 
cells have just begun to express Pitx3 and the expression level is not yet detectable 
by immunostaining. On the other hand these cells may not be expressing Pitx3, but 
may require factors from the Pitx3-GFP+ cell population for their induction and/or 
maintenance. This hypothesis could be addressed by chimera experiments with Pitx3 
null ES cells and wild type embryos or vice versa. For example, it would be expected 
that the loss of Pitx3 null Pitx3-GFP-TH+ cells at E12.5 would be rescued if there was 
a high contribution of wild type cells compared to Pitx3 null cells in the midbrain. 
Similarly you would expect loss of wild type Pitx3-TH+ cells at E12.5 if there was a 
high contribution of Pitx3 null cells and a low contribution of wild type cells in the 
chimeric midbrain.  
From the TUNEL assay, Nissl staining and primary culture results it is likely that the 
absence of any Pitx3-GFP+ and TH+ cells in the Pitx3 null adult SNc is due to 
apoptotic cell death during development. The TUNEL assay showed that around 
double the number of Pitx3-GFP+ cells in the Pitx3 null SNc are undergoing 
apoptosis compared to the Pitx3 heterozgyous SNc and VTA or the Pitx3 null VTA. 
The primary culture of E14.5 midbrain revealed comparable results to the TUNEL 
assay with around a two-fold increase in the number of Pitx3-GFP+ cells in the Pitx3 
null culture undergoing apoptosis as compared to the Pitx3 heterozygous culture. As 
the Pitx3 null SNc cells lose or fail to express TH it was possible that these cells did 
not die but changed fate into another neuronal subtype. As well as dopaminergic 
neurons, GABAergic neurons are also present in the VTA and SNc. The adult VTA 
and SNc contain around 15-25% GABAergic neurons whilst the remainder are 
dopaminergic (Bayer and Pickel, 1991). The results show that none of the E12.5 or 
E14.5 Pitx3-GFP+ neurons are GABAergic and that approximately all Pitx3-GFP+ 
cells expressed a DA marker (En1). However, the possibility of fate change in Pitx3 
null SNc cells cannot be ruled out, as if the cells no longer express Pitx3-GFP, their 
fate cannot be traced. 
 
Taking these results together this study has revealed that the homeodomain 
transcription factor Pitx3 is required for TH expression and survival of SNc mDA 
neurons but not VTA neurons. A loss or downregulation of TH in mDA cells does not 
impair their survival, in TH knock-out mice the mDA neurons were found to be intact 
as revealed by staining with an antibody against L-aromatic amino acid 
decarboxylase (AADC), which is the enzyme that converts L-DOPA to dopamine 
(Zhou and Palmiter, 1995). This suggests that the two functions of Pitx3 in TH 
regulation and survival in SNc mDA neurons are likely to be regulated separately.  
As the SNc neurons appear to die via apoptosis in Pitx3 null mice, Pitx3 may be 
involved in the regulation of pro- or anti-apoptotic genes. Neuronal apoptotic cell 
death is a well recognised phenomenon characterised by morphological cell changes 
including chromatin condensation, nuclear fragmentation, cytoplasmic shrinkage and 
plasma membrane blebbing (Yuan et al., 2003).  More recently the molecules and 
cellular processes regulating apoptotic cell death are being uncovered. So far, some 
key molecules that are implicated in neuronal apoptosis are members of the Bcl-2, 
caspase and Apaf-1 families. The Bcl-2 family has both pro- and anti-apoptotic 
members, for example, Bcl-2 and Bcl-xL are anti-apoptotic Bcl-2 proteins and Bax 
and Bak are pro-apototic Bcl-2 proteins that are expressed in the embryonic nervous 
system (Krajewska et al., 2002). The exact mechanisms by which Bcl-2 proteins act 
remain unclear, however it has been shown that mitochondrial release of cytochrome 
c is a crucial event in caspase activation and that Bcl-2 family members can regulate 
outer mitochondrial membrane permeability and thus release of cytochrome c (Harris 
and Thompson, 2000). Bcl-xL is a member of the Bcl-2 family that has been linked 
with apoptosis in SNc mDA neurons (Savitt et al., 2005).  Bcl-xL is a product of the 
Bcl-x gene which can be alternatively spliced to produce two protein isoforms, the 
anti-apoptotic Bcl-xL, which mediates most nervous system effects, and the pro-
apoptotic Bcl-xS, which is expressed at low or undetectable levels in the brain 
(Krajewska et al., 2002).  Mutation of the Bcl-x gene in mice results in a huge loss of 
neurons and haematopoietic cells and embryonic lethality at E13.5 in Bcl-x null mice 
(Motoyama et al., 1995). The effects of Bcl-x proteins in dopaminergic neurons were 
investigated by performing a conditional Bcl-x knock-out in which mice with Cre 
expressed under the control of the TH promoter were crossed with mice containing a 
loxP flanked Bcl-x gene.  In the SNc of these mice there were around a third fewer 
mDA neurons and a similar loss of neurons was observed in all catecholaminergic 
cells studied. Many of the remaining neurons expressed TH and Bcl-x, suggesting 
that the Cre-mediated excision had not worked in these cells (Savitt et al., 2005). 
Thus, it is likely that in the majority of SNc mDA cells Bcl-xL is required for cell 
survival.  The expression profile of Bcl-xL in the developing nervous system peaks at 
around E13 to P7 (Krajewska et al., 2002), which coincides with the appearance of 
mDA neurons and the death of SNc mDA cells in Pitx3 null mice (Ch. 5.2). Cell death 
in Bcl-x knock-out mice occurs in post-mitotic but immature neurons (Motoyama et 
al., 1995; Roth et al., 1996). Additionally there is an increase in Bcl-xL expression 
during the differentiation of DA neurons from ES cells (Shim et al., 2004). This data 
implies a possible role for Pitx3 in regulation of the Bcl-x gene in the SNc, either 
directly or by a downstream target of Pitx3.  
As Pitx3 is expressed in both the SNc and VTA mDA neurons it might be expected 
that it functions similarly in both populations. However analysis of the Pitx3 null mice 
has shown that it is specifically required in the SNc mDA neurons where it has at 
least two functions, one is the regulation of TH expression and the other is cell 
survival (Ch. 5.2).  Therefore, it is possible that there are cell-specific factors that 
are yet to be identified, which interact with Pitx3 to produce these cell-specific 
effects. Although no evidence exists for Pitx3 interacting partners in mDA neurons, 
it seems likely from studies on similar proteins. A number of transcriptional targets 
and interacting partners have been identified for Pitx1 and Pitx2. Both of these Pitx 
factors are able to act as transcriptional regulators of many pituitary hormones 
including POMC (Lamonerie et al., 1996), glycoprotein hormone -subunit ( GSU), 
growth hormone (GH), prolactin (Szeto et al., 1996; Tremblay et al., 1998), thyroid 
stimulating hormone (TSH) (Tremblay et al., 1998), luteinizing hormone 
 
(LH ) 
(Quirk et al., 2001), follicle-stimulating hormone (FSH ) (Zakaria et al., 2002) and 
gonadotrophin-releasing hormone (GnRH) (Tremblay and Drouin, 1999). Pitx1 
displays cooperative interactions with both early growth response 1 (EGR1) and 
steroidogenis factor 1 (SF1, NR5A1) (Tremblay and Drouin, 1999; Tremblay et al., 
1999). While Pitx2 has been shown to interact with the POU homeodomain protein 
Pit-1 (Bach et al., 1997; Szeto et al., 1996). Other studies have established that Pitx 
homeodomain family members can activate transcription via direct protein-protein 
interactions with cell restricted transcription factors such as NeuroD1, a member of 
bHLH family of transcription factors, and Tpit, a T-box factor (Lamolet et al., 2001; 
Poulin et al., 2000). The interaction of Pitx factors with bHLH factors is interesting as 
bHLH factors are involved in neurogenesis and promote a neural fate in vivo (Lee, 
1997). For example, in sympathetic neurons the paired like transcription factors 
Phox2a and Phox2b interact with bHLH factors to regulate neurotransmitter 
phenotype by activating dopamine -hydoxylase (Morin et al., 1997; Pattyn et al., 
1997). Another potential Pitx3 interacting partner is Ldb1 which is a cofactor that is 
able to bridge between LIM-HD proteins and Pitx proteins (Bach et al., 1997).  The 
expression of Lmx1b not only overlaps with Pitx3 in mDA neurons, but also with 
Pitx2 in the subthalamic nucleus (STN), posterior hypothalamus and some 
mammillary nuclei where Ldb1 is also expressed (Asbreuk et al., 2002).  Therefore, 
Ldb1 may mediate cooperation between Lmx1b and Pitx factors in these regions.    
8.4. Pitx3 acts in a cell autonomous manner 
Studies have shown that the homeodomain transcription factor En2 can be secreted 
and taken up by other cells in vitro, suggesting that it may have the capacity to act as 
an intercellular signal in vivo (Joliot et al., 1998; Maizel et al., 1999). A chimera study 
was carried out to investigate the possibility that Pitx3 may be able to act 
intercellularly, or if any molecules downstream of Pitx3 were present in the midbrain 
environment and able to rescue Pitx3 null SNc cells. The chimera study indicates that 
Pitx3 null ES cells are severely compromised in their ability to contribute to the SNc 
compared to Pitx3 heterozygous ES cells. This suggests that neither Pitx3 nor any of 
its downstream targets present in the wild type embryo are able to act in a cell non-
autonomous manner to enable the Pitx3 null cells to integrate and survive in the SNc. 
Therefore, it appears that Pitx3 acts in a cell autonomous manner in mDA neurons. 
Due to the competition between wild type and mutant cells in a chimera situation, 
chimera studies are able to give additional insights into the phenotype of mutations. 
This chimera study revealed that the Pitx3 heterozygous ES cells were also 
compromised in their ability to contribute to the SNc. As the Pitx3 heterozygous mDA 
phenotype cannot be distinguished from wild-type this Pitx3 haploinsufficiency is only 
evident when these cells are challenged as in the chimera situation where there is 
competition between Pitx3 heterozygous and wild type cells. Homeodomain 
transcription factor haploinsufficiency is common and especially manifests in many 
cases of human disease (Seidman and Seidman, 2002). For example, the loss of 
one allele of Pitx2 causes Reiger Syndrome in humans and a similar phenotype in 
mice characterised by abnormalities of the anterior chamber of the eye, dental 
hypoplasia, craniofacial dysmorphism and iris hypoplasia, (Gage et al., 1999; Semina 
et al., 1997). Furthermore, cateracts and anterior segment mesenchymal dysgenesis 
(ASMD) in humans are caused by Pitx3 haploinsufficiency (Semina et al., 1998). It 
would be interesting to further investigate the haploinsuffiency of Pitx3 in the mDA 
neurons. This could be done by challenging the Pitx3 heterozygous mDA neurons 
with mDA-specific toxic agents such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 
(MPTP) or 6-hydroxydopamine (6-OHDA), for example. This may reveal that Pitx3 
heterozygous mDA neurons are more vulnerable than wild-type neurons when 
challenged with toxins.  
8.5. Pitx3 expression and function defines the SNc and VTA subgroups 
The SNc and VTA mDA neurons are anatomically and functionally distinct groups of 
neurons, however, currently there are few markers that are able to distinguish 
between them. The most utilized markers are Girk2 and calbindin which are 
expressed in the SNc and VTA respectively, although this expression is not 
completely exclusive. The G-protein-gated inwardly rectifying K+ channel Girk2 is 
expressed in most SNc mDA neurons and has been used as a marker for SNc 
neurons (Thompson et al., 2005), however, it is also expressed in the more lateral 
VTA mDA neurons (Schein et al., 1998). The calcium binding protein calbindin is 
expressed in the vast majority of the VTA mDA neurons, but many cells of the SNc 
have been reported to express calbindin as well (Liang et al., 1996). Furthermore, 
these markers can only distinguish between SNc and VTA neurons in adult mice 
and both Girk2 and calbindin are expressed in the SNc and VTA in embryonic and 
early postnatal mDA neurons (M. Parmar, unpublished observations). Therefore, in 
order to understand the differences between these neurons it is necessary to be 
aware of the different ontogeny and expression profiles of the SNc and VTA 
neurons.  
In the adult mouse midbrain the vast majority of mDA neurons in the SNc and VTA 
express both TH and Pitx3. However, this study has revealed that Pitx3 has different 
roles in the SNc and VTA and that mDA neurons arise from two distinct 
subpopulations of cells identified by their differential expression profiles of Pitx3 and 
TH. At E12.5 a population of mDA neurons in the midbrain express TH but not Pitx3 
and another population of cells express Pitx3 but not TH. It is likely that the Pitx3+TH- 
population of cells at E12.5 are mDA precursors as they express the neuronal and 
mDA marker genes, tubulin3 and En1, respectively, and they do not express 
markers for mitotic cells, glial cells or GABAergic neurons. Over the next few days of 
embryonic development the Pitx3-TH+ and Pitx3+TH- cells begin to express Pitx3 and 
TH, respectively, and eventually almost all mDA neurons express both Pitx3 and TH. 
The developmental heterogeneity within the mDA population revealed in this study 
implies that mDA neuron development proceeds via both Pitx3-dependent and Pitx3-
independent mechanisms, and that this distinction in ontogeny is reflected in the 
selective vulnerability of the SNc mDA lineage in Pitx3 null mice. It is not possible to 
identify which adult cell populations these E12.5 subgroups will form due to a 
combination of the architecture of the mDA neurons and the lack of markers able to 
distinguish between SNc and VTA neurons at this stage of development. However, 
there are a number of lines of evidence to suggest that these ontogenetically distinct 
subgroups at E12.5 do form the SNc and VTA, respectively.   
Firstly, the position of these groups at E12.5 is indicative that the more lateral 
Pitx3+TH- group will migrate most laterally to form the SNc, whereas the Pitx3-TH+ 
group are in a more medial start position so are more likely to form the VTA. The 
route by which mDA neurons migrate from the ventricular zone and come to their 
final destination is controversial. Some studies suggest that mDA precursors are 
generated in the most medial and ventral part of the neuroepithelium and migrate 
ventrally down the midline before migrating laterally to their final position, in a so 
called ‘inverted fountain’ model (Fig. 8.1.A) (Hanaway et al., 1971; Kawano et al., 
1995; Marchand and Poirier, 1983). On the other hand, it has been proposed that 
mDA precursors are generated from the medial ventral one-third of the ventricular 
zone and migrate radially, perpendicular to the ventricle (Fig. 8.1.B) (Smidt et al., 
2004). The orientation of the TH+ neurons in the midbrain at E12.5 in this study 
supports this ‘inverted fountain’ model of mDA neurogenesis. Analysis of mDA cell 
bipolar orientation at E12.5 revealed that the TH+ cells located closer to the medial 
part of the neuroepithelium exhibited an orientation suggestive of a vertical migration 
route, whereas TH+ cells located in a lateral position had an orientation suggestive of 
a horizontal migration route (Ch 4.2.3). Additional data in this study supporting the 
‘inverted fountain’ migration pattern is that some Pitx3-GFP+ cells in a more medial 
position were Tubulin3-negative (Ch. 3.2). This would correlate with the ‘inverted 
fountain’ model of mDA neurogenesis and migration as the medial cells are less 
mature than the more lateral cells and thus have not yet started to express 
Tubulin3. If the ‘inverted fountain’ model of migration does occur then it is likely that 
the more ventral and lateral Pitx3+TH- population at E12.5 will become the SNc while 
the more dorsal and medial Pitx3-TH+ population at E12.5 will become the VTA. 
However, the possibility that a combination of both modes of migration may occur 
cannot be ruled out.   
 
Secondly, over the course of the next few days after the distinct subpopulations 
visible at E12.5, almost all mDA neurons in the midbrain of Pitx3 heterozygous mice 
express both Pitx3 and TH except some at the most lateral region of the SNc at 
E14.5 which still are Pitx3+TH- (Ch. 4.2). This further implies that the E12.5 Pitx3+TH- 
population will become SNc neurons as the remnants of this population are present 
in the SNc primordium at E14.5. A third line of evidence is the fact that a loss of Pitx3 
only affects the SNc neurons even though it is expressed in both SNc and VTA. This 
differential dependence on Pitx3 reveals that Pitx3 has diverse roles and may have 
distinct interacting partners in these functionally distinct mDA neuron populations. 
Thus, it is likely that there is a differential regulation of Pitx3 expression with respect 
to TH expression in the SNc and VTA.  
8.5.1. Do the ontogenetically distinct subgroups at E12.5 distinguish the SNc 
and VTA? 
This subregional heterogeneity may provide a basis for different developmental 
pathways for the anatomically and functionally distinct SNc and VTA subpopulations. 
To address this problem a fate mapping study has been designed to track the 
migration of the earliest Pitx3 expressing cells, i.e. the population of cells that are 
Pitx3+TH- at E12.5. ES cells with CreERT2 under the control of the endogenous Pitx3 
promoter have been generated and mice carrying this allele are in production (Ch. 7). 
By crossing these mice with another line of transgenic mice containing a Cre-
dependent reporter gene under the control of a ubiquitous promoter, the expression 
of the reporter gene will be controlled both spatially and temporally. Thus the reporter 
gene expression will be dependent upon the expression of Pitx3-CreERT2 and the 
presence of the synthetic ligand tamoxifen. Therefore, the cells that express Pitx3 at 
E12.5 can be labelled with the reporter then the midbrains can be examined at later 
stages of development to establish where the labelled cells are located. This will 
ascertain whether the E12.5 Pitx3+TH- cell population contributes to the SNc, VTA or 
both areas and thus test the hypothesis discussed above. In addition this analysis 
should help to build up a clearer picture of the pattern of mDA neuron migration.   
8.5.2. Further applications of Pitx3-CreERT2 mice 
As well as being a tool for tracking the fate of early Pitx3 expressing cells, the Pitx3-
CreERT2 mice may be used to conditionally knock-out genes in a mDA specific 
manner. This will be particularly useful to disrupt the expression of genes that may be 
involved in mDA neuron regulation but due to their other role(s) the conventional 
knock-out is embryonic lethal or the disruption caused by the knock-out is too 
widespread in the CNS to distinguish the mDA phenotype. For example, Lmx1b is 
expressed in mDA neurons, however it is also expressed in other brain areas and 
throughout the mesencephalon and diencephalon from E7.5 (Smidt et al., 2000). 
Consequently, it is difficult to analyse the effect of a lack of Lmx1b on mDA neurons 
in the Lmx1b knock-out as there are large mid- and hindbrain deletions which may 
affect mDA neuron development (Smidt et al., 2000). Similarly in the Engrailed 1 and 
2 double knock-out there is a substantial truncation of the midbrain and anterior 
hindbrain resulting in a loss of the isthmus and reduced levels of Shh and FGF8 
(Simon et al., 2001).  Therefore, a conditional knock-out of these genes using the 
Pitx3-CreERT2 mice may reveal the true function of these genes in mDA neurons.   
In addition, the Pitx3-CreERT2 mice will be a useful tool to track the fate of Pitx3 null 
SNc mDA neurons. The evidence in this study suggests that Pitx3 null SNc neurons 
die rather than change fate into another cell type (Ch. 6.2). However, the possibility 
that some of these cells down-regulate Pitx3-GFP and TH expression and begin to 
express other cell-type specific markers cannot be ruled out. The Pitx3-CreERT2 mice 
crossed with a Cre-dependent reporter mouse will be able to address this problem as 
all cells which express Pitx3-CreERT2 can be permanently labelled by Cre-mediated 
activation of the reporter gene expression. Thus, the fate of any labelled cells can be 
tracked.   
8.6. Comparison of Pitx3 null with aphakia 
During the course of this work, a number of studies on the mDA phenotype of the 
naturally occurring mouse mutant aphakia were published.  Of the studies that 
investigated the mDA phenotype during embryonic development, one reported no 
difference between aphakia and wild type mDA neurons at E12.5 (Van Den 
Munckhof et al., 2003). Another study showed that aphakia mice had aberrant 
positioning of TH+ neurons at E12.5, with fewer neurons in a rostral-lateral position 
and more in a dorsal-medial position compared to wild type, although a reduction in 
TH+ cell number was not detected (Smidt et al., 2004).  These findings in aphakia 
mice are in contrast to the findings in this study of Pitx3 null mice in which there is a 
loss of more than half of the TH+ neurons at E12.5 compared to wild type (Ch. 5.2). 
Studies on aphakia also revealed a loss of the most lateral TH+ cells at E14.5 
(Nunes et al., 2003; Smidt et al., 2004), however no quantitative data is available to 
determine if this loss is comparable to the Pitx3 null phenotype in which there is a 
deficit in TH+ neurons in the SNc of more than 50% at E14.5 (Ch. 5.3).  
The majority of the studies on post-natal and adult aphakia mice were in 
concurrence with this study on Pitx3 null mice, in that there is a complete loss of 
SNc neurons while the VTA remains much less affected (Hwang et al., 2003; Nunes 
et al., 2003; Smidt et al., 2004). On the contrary, van den Munckhof et al. report a 
loss of TH+ neurons in the majority of the SNc except for the most dorsal tier of this 
structure and a loss of half the TH+ neurons in the VTA. This correlates with their 
claims that Pitx3 is not expressed in most of the dorsal SNc mDA neurons and only 
expressed in around half of the VTA mDA neurons (Van Den Munckhof et al., 
2003). However, these observations were neither supported by this study nor by 
that of Smidt et al., which clearly demonstrate that Pitx3 and TH expression overlap 
completely throughout the SN and VTA (Ch. 3.2) (Smidt et al., 2004) and that loss 
of Pitx3 results in a complete loss of SNc mDA neurons (Ch. 5.2).   
The four published studies on the midbrain phenotype of aphakia mice support the 
findings in this study that Pitx3 null SNc neurons die.  Nissl staining in aphakia mice 
revealed an absence or a reduction in the number of neurons in the SNc of aphakia 
mice (Hwang et al., 2003; Nunes et al., 2003; Smidt et al., 2004; Van Den Munckhof 
et al., 2003). Furthermore, evidence for apoptotic cell death was revealed by 
TUNEL labelling in the aphakia mice (Van Den Munckhof et al., 2003) which is 
comparable to the results in this study (Ch. 6.2).  
The aphakia studies and this study of Pitx3 null reveal that the phenotypes of these 
mice are largely similar. However, the apparently more severe mDA defect in the 
Pitx3 null is probably due to the creation of a true null mutation by gene targeting, 
since the entire Pitx3 coding region is deleted in the targeted Pitx3 locus (Zhao et 
al., 2004). In contrast, the entire coding sequence remains intact in aphakia mice, 
which have 1±5% of the wild type level of Pitx3 transcript from E11 to newborn 
(Rieger et al., 2001).    
8.7. Pitx3 null as a model for Parkinson’s Disease 
Parkinson’s disease (PD) is characterised by the progressive loss of mDA 
substantia nigra neurons resulting in the depletion of dopamine in the striatum. Thus 
PD affects the motor control system and the symptoms include tremor at rest, 
postural imbalance, slowness of movement, difficulty in initiating movement and 
rigidity (Lotharius and Brundin, 2002). The specific aetiology of PD is unclear, it 
seems that both genetic and environmental factors are involved. Rare familial cases 
of PD (0.5% of cases) have been linked to mutations in some genes such as Parkin, 
synuclein and ubiquitin-C-hydrolase-L1 (UCHL1). On the other hand, a range of 
factors including environmental toxins, oxidative stress and mitochondrial 
dysfunction have been implicated as non-genetic pathogenic mechanisms 
(Lotharius and Brundin, 2002). PD affects around 1% of the population over 65 
years old and current treatments are mainly drug-based, which often have 
undesirable side effects (Klockgether, 2004). Therefore, there is much interest in 
animal models of PD which can be used to study the pathogenesis and develop 
treatments for this disease.   
Ideally, an animal model for PD would have a full complement of mDA neurons at 
birth and the SNc mDA neurons would be selectively lost later in life. The loss of SNc 
mDA neurons should be at least 50-70%, the number which results in clinical 
symptoms in humans. In addition, the animal should display motor deficits similar to 
the main symptoms of PD.  Current animal models of PD include the toxin-induced 
models using 6-hydroxydopamine, rotenone and 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) to ablate substantia nigra mDA neurons (Beal, 2001). 
More recently transgenic mice models with mutations in or overexpression of -
synuclein and parkin genes have been developed (Beal, 2001). At present the MPTP 
neurotoxicity model is the best of these animal models as it selectively targets the 
substantia nigra neurons and reproduces all the clinical signs of PD in primates. The 
main problem with this model is that it is an acute process rather than a slow 
progressive loss of mDA neurons as in PD. Furthermore, toxin-induced models of PD 
are not ideal due to the labour intensive toxin injections and the need to assess the 
degree of the lesion in each case. Thus genetic models of PD would be of great use 
for standardised high throughput screening of novel therapies for PD.  
The specific loss of SNc mDA neurons in Pitx3 null mice makes them a potential 
genetic animal model for PD. Although the behaviour of the Pitx3 null mice has not 
been studied it is thought that it will be similar to that of aphakia mice. However, 
reports on the aphakia behavioural phenotype are inconsistent, in one study 
aphakia mice showed around 50-70% reduction in ambulatory and stereotypic 
activities and spent more time resting compared to wild type (Van Den Munckhof et 
al., 2003). In contrast, Nunes et al. found that general locomotor behaviour 
appeared to be higher in aphakia as compared to wild type (Nunes et al., 2003). 
Another study stated that Aphakia mice had no altered posture, walking pattern or 
tremor, but they did have lower overall activity in an open field test and increased 
activity in a climbing test as compared to wild type (Smidt et al., 2004). A more 
recent study which focussed particularly on the behavioural phenotype of aphakia 
mice reported that there was no impairment in overall spontaneous locomotor 
activity (Hwang et al., 2005). Yet tests that were sensitive to nigro-striatal 
impairments, such as the challenging beam test, spontaneous exploratory 
behaviour test and the pole test, revealed that the aphakia mice displayed specific 
motor deficits. Importantly these impairments could be restored to wild type levels 
by treatment with the PD medication 3,4-dihydroxyphenylalanine (L-DOPA), which 
is a precursor of dopamine thus it compensates for the loss of dopamine from SNc 
neurons (Hwang et al., 2005). Further support that aphakia mice represent a valid 
model for PD is provided by their display of denervation supersensitivity of the 
striatum, which is an altered responsiveness of striatal neurons to dopamine. This 
occurs in PD patients and animal models of PD and can be reflected by the L-
DOPA-mediated induction of the immediate early gene c-fos in the striatum (Hwang 
et al., 2005).  
In Pitx3 null mice (Ch. 6.2) and aphakia mice (Van Den Munckhof et al., 2003) SNc 
cells appear to die via apoptosis, however, the mode of cell death in PD remains 
controversial. Some studies have shown evidence for apoptotic cell death such as 
nick-end labelling (Mochizuki et al., 1996), DNA cleavage and chromatin clumping 
(Tatton et al., 1998) in SNc cells from brains of PD patients. Besides morphological 
evidence, factors involved in apoptotic pathways have been identified in SNc cells of 
PD patients. For example, activated caspase-3, a key player in mediating apoptosis 
(Hartmann et al., 2000) and activated caspase-8, a proximal effector protein of the 
tumor necrosis factor receptor family death pathway (Hartmann et al., 2001), have 
been found in more SNc cells of PD patients compared to control. However, other 
studies have found no evidence of apoptotic cell morphology such as nick-end 
labelling and no sign of up-regulation of apoptosis associated genes such as Bcl-x, 
Bcl-2, Bax and activated caspase-3 (Jellinger, 2000; Kosel et al., 1997).   
In comparison to other existing transgenic models of PD, such as -synuclein and 
parkin gene disruptions, the Pitx3 null mice seems to be the most favourable due to 
the SNc specific loss of mDA neurons. Although, the rate of mDA neuron loss and 
the presumed behavioural phenotype of the Pitx3 null mice do not correlate well with 
PD. The lack of a severe behavioural phenotype in Pitx3 null mice could be due to 
compensatory mechanisms as a result of the early developmental loss of the SNc 
neurons. Therefore, a model in which Pitx3 was conditionally knocked-out at a later 
stage in life may represent a better model of PD.   
8.8. Concluding remarks 
The work in this thesis has revealed that Pitx3 is specifically required for SNc mDA 
neuron survival and regulation of TH expression. Furthermore, this study has 
uncovered that during embryonic development there are two ontogenetically distinct 
groups of mDA neurons based on their expression of Pitx3 and TH.  However, the 
picture of mDA neuron specification and development remains far from complete. 
Clearly there are many factors involved in mDA neuron specification and 
development that are yet to be uncovered. Future studies also need to address the 
relationships and interactions between the factors involved in the regulation of mDA 
neuron development and survival. Acquiring this knowledge may lead to a greater 
understanding of the pathogenesis of these neurons in human disease and aid in 
the realisation of the goal to derive pure populations of mDA neurons, possibly SNc-
like mDA neurons, from ES cells. 
 
Figure 8.1. Models of mDA neuron migration. 
Coronal sections of E12.5 midbrain with TH immunostaining are shown with the two 
proposed models of mDA neuron migration represented by arrows from the 
neuroepithelium which is indicated by a double line (A and B). Model A shows 
vertical migration from the most medial and ventral part of the neuroepithelium 
followed by lateral migration. This model is also known as the ‘inverted fountain’ 
model. Model B shows a pattern of radial migration from the medial and ventral one 
third of the neuroepithelium. Adapted from (Smidt et al., 2004).                 
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